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ABSTRACT
David Michael Lee: A 5′ fragment of Xist can sequester RNA produced from adjacent genes on 
chromatin 
(Under the direction of J. Mauro Calabrese) 
 
Genome regulation is essential for normal human health and development. Each cell in 
the body has the same copy of the entire genome but must express different genes at different 
times and to different levels. Control of gene transcription is a major mechanism of genome 
regulation, and one form of transcriptional control is mediated by long noncoding RNAs 
(lncRNAs), RNAs longer than 200 nucleotides which do not code for proteins. A key example of 
this is the function of the X-inactive specific transcript (Xist) in X chromosome inactivation in 
female eutherian mammals. 
Xist requires Repeat-A, a protein-binding module in its first two kilobases (2kb), to 
repress transcription. We report that when expressed as a standalone transcript in mouse 
embryonic stem cells (ESCs), the first 2kb of Xist (Xist-2kb) does not induce transcriptional 
silencing. Instead, Xist-2kb sequesters RNA produced from adjacent genes on chromatin. 
Sequestration does not spread beyond adjacent genes, requires the same sequence elements in 
Repeat-A that full-length Xist requires to repress transcription, and can be induced by lncRNAs 
with similar sequence composition to Xist-2kb. We do not detect sequestration by full-length 
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Xist, but we do detect it by mutant forms of Xist with attenuated transcriptional silencing 
capability. Xist-2kb associates with SPEN, a Repeat-A binding protein required for Xist-induced 
transcriptional silencing, but SPEN is not necessary for sequestration. Thus, when expressed in 
mouse ESCs, a 5′ fragment of Xist that contains Repeat-A sequesters RNA from adjacent genes 
on chromatin and associates with the silencing factor SPEN, but it does not induce 
transcriptional silencing. Instead, Xist-induced transcriptional silencing requires synergy between 
Repeat-A and additional sequence elements in Xist. We propose that sequestration is 
mechanistically related to the Repeat-A dependent stabilization and tethering of Xist near 
actively transcribed regions of chromatin. We also describe initial efforts to explore the possible 
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CHAPTER 1: INTRODUCTION
1.1 Gene expression regulation 
Genome regulation is a vital aspect of normal human health and development. Every cell 
in the human body has a role to play, based on its identity and context. The job of a muscle cell 
is very different from that of a skin cell or a cell in the eye. However, all cells contain the same 
set of instructions: a complete copy of the genome. A key aspect of understanding cellular 
function, then, is to understand how the same set of genes specifies the function of myriad 
different cell types at different times throughout human development and in response to the wide 
array of environmental stimuli encountered. Simply knowing the sequence of the genome is not 
enough. Rather, we need to understand how the expression of different genes to different levels 
is regulated. This effort is important for understanding normal human development, but also for 
attempts to treat the many diseases and disorders which result from improperly regulated gene 
expression.  
A major mechanism of genome regulation is control of gene transcription. By regulating 
the timing and extent of gene transcription, cells can control the resulting levels of protein 
products encoded by those genes. In this way, the same genome can be used to encode a variety 
of different functions depending on the cell type, developmental stage, and environmental 
context. Investigating transcriptional regulation will add to our fundamental understanding of 
how cells function in normal development. Additionally, many diseases result from dysregulated 
gene expression. The prime example of this is cancer, which often results from over- or under-
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expression of genes controlling cell cycle, leading to unchecked, malignant growth and 
development of tumors. 
Because gene expression regulation is a fundamental mechanism, it is important to focus 
in on specific examples as we seek to understand it. The example considered here is control of 
gene expression by long noncoding RNAs (lncRNAs). More specifically, we probe the 
mechanism of the X-inactive specific transcript (Xist) lncRNA, which coordinates a remarkable 
series of epigenetic changes leading to transcriptional silencing of nearly all of the genes on one 
of the X chromosomes in female mammalian cells in a process called X chromosome 
inactivation (XCI). 
1.2 Long noncoding RNAs 
Long noncoding RNAs are defined as RNAs longer than 200 nucleotides which do not 
encode protein products. As RNA sequencing technology has improved in the past decade, we 
have found many genes throughout the genome that are transcribed without coding potential. In 
fact, whole transcriptome studies have revealed that protein-coding regions make up only 2% of 
the human genome, although the majority of it can be transcribed (1,2). Of the approximately 
59,000 annotated human genes in the current GENCODE release (version 30), approximately 
16,000 (~27%) are annotated as lncRNA genes (3). Similarly, in mice, approximately 24% of 
annotated genes are lncRNAs (GENCODE version M21; (3)). While some transcribed lncRNAs 
may be nonfunctional, the consistent transcription of so many lncRNAs, requiring significant 
cellular resources, suggests that many have important, evolutionarily conserved functions. 
Indeed, many examples of functional lncRNAs have been found, displaying roles in nuclear 
structure (4), cell differentiation (5), genomic imprinting (6), viral infections (7), and genome 
regulation (4,8,9). Importantly, lncRNAs have been linked to cancer and other human diseases 
(10,11), either as contributing factors or as biomarkers. 
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One important example of lncRNA function is transcriptional regulation. Multiple 
lncRNAs have been described which can influence the transcription of other genes (4). Some of 
these, including the lncRNAs Airn, Kcnq1ot1, and Xist, function to repress genes in cis, meaning 
that they repress genes on the same chromosome from which they are expressed (12). A major 
question regarding these lncRNAs is how their functions are encoded. It seems likely that most 
of their repressive activity is carried out by recruitment of effector proteins. More specifically, 
Xist has been shown to recruit proteins via discrete, modular domains (13-16). Many of these 
proteins contribute to epigenetic changes which lead to formation of heterochromatin domains 
and reduced gene expression. Understanding the mechanisms by which these lncRNAs act in cis 
and repress gene expression will further our knowledge of gene expression regulation, 
transcription, and epigenetics. Because Xist is the most well-studied of the repressive lncRNAs, 
we have focused our efforts on probing its function. 
1.3 Xist and X chromosome inactivation 
Xist is essential for the process of X chromosome inactivation (XCI) in female eutherian 
mammals, which leads to selective silencing of nearly all of the genes along the 165 megabase 
inactive X (Xi) and results in equalization of gene dosage between female cells and male cells, 
which only have one X chromosome. Xist itself is upregulated from the future Xi early in 
development and orchestrates a series of epigenetic changes which lead to heterochromatin 
formation and stable silencing of the chromosome. The remarkable potency of Xist, its tight 
regulation of broad epigenetic changes, and its central role in normal female development all 
make it an important lncRNA to understand. Understanding the mechanism by which Xist 
localizes to the Xi and recruits epigenetic modifiers will shed light on lncRNA-mediated gene 
expression regulation in general. 
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Following upregulation, Xist spreads across the Xi, leading to a series of changes. These 
include exclusion of RNA polymerase, removal of active histone marks, and recruitment of 
repressive histone marks. Eventually, the DNA of the Xi is heavily methylated, the Xi is tethered 
to the nuclear periphery, and the chromatin is tightly packed (17). Xist is not known to be 
catalytic on its own, so its function is presumed to be largely dependent on recruitment of a 
specific set of effector proteins. By bringing these proteins together in specific combinations and 
at specific places on the Xi, Xist orchestrates XCI. Although Xist is not strongly conserved at the 
sequence level, the presence of several internal tandem repeat domains in the sequence is 
conserved (18-21), and these repeats have been shown to recruit various cofactor proteins in a 
modular fashion (13-16). In this way, Xist serves as a prototype for research into how lncRNAs 
function by recruiting proteins through modular domains. 
Several recent studies have focused on identifying these protein cofactors through 
proteomic and genetic screening methods (13,22-25). Some of these proteins have known 
functional links to gene repression. The most notable is SPEN, which has been identified in 
multiple studies as an Xist interactor which is required for Xist-induced silencing (13,22,24,25). 
SPEN is known to interact with the SMRT-HDAC complex, which mediates histone 
deacetylation, RNA polymerase II exclusion, and transcriptional silencing (17,26-28). 
Additionally, Xist expression leads to recruitment of the Polycomb Repressive Complexes (PRC) 
PRC1 and PRC2, which catalyze well-known repressive histone marks which are important for 
XCI (29-31). Other proteins have been shown to be involved in proper Xist localization, such as 
HNRNPU (32). 
Intriguingly, though, a number of required Xist cofactors have unclear roles in XCI. For 
example, the export proteins NXF1 and RBM15 were identified in an shRNA screen for Xist 
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cofactors (24), but it is unclear how they are contributing to Xist-induced silencing. Another 
required protein is WTAP, which mediates m6A methylation in RNA (24). Though it has 
recently been shown that m6A methylation of Xist RNA is important for Xist-induced silencing 
(33), the reason for this is unclear. These protein cofactors, along with other examples, indicate 
the major questions still surrounding the mechanism of Xist-induced gene silencing. We have 
developed a novel system to study the role of Xist in initiating silencing. We describe a 
surprising finding that expression of portions of Xist, as well as expression of several lncRNAs 
with similar sequence, can repress gene expression by sequestering mRNA transcripts of nearby 
genes on chromatin, preventing translation, rather than through transcriptional silencing. To our 
knowledge, this is the first observation of lncRNA expression leading to gene expression 
regulation through nuclear retention of mRNA. This work describes the initial observation and 
characterization of the sequestration phenomenon (Chapter 2), as well as our initial attempts to 
understand the mechanism of sequestration (Chapter 2 and 3). 
6 
CHAPTER 2: A 5′ FRAGMENT OF XIST CAN SEQUESTER RNA PRODUCED FROM 
ADJACENT GENES ON CHROMATIN1
2.1 Introduction 
Long noncoding RNAs (lncRNAs) play essential roles in development and homeostasis 
by regulating gene expression (2). Emerging data suggest that lncRNAs encode regulatory 
function in a modular fashion via discrete domains that each recruit effector proteins to carry out 
specific actions (13-15,34-39). An example of this modularity comes from studies of the lncRNA 
Xist, which functions to silence nearly all genes along the 165 megabase (Mb) X chromosome as 
part of X-chromosome inactivation (XCI), the dosage compensation process that occurs early 
during the development of eutherian mammals. At the level of sequence composition, Xist is 
notable for the presence of several internal domains of tandem repeats (18-21).  These repeats 
have been shown to recruit different subsets of RNA-binding proteins that help Xist achieve 
repressive function, and in this regard, they can be considered as functional modules (13-15,39). 
One such repeat is found in the first thousand nucleotides of Xist and is called “Repeat-
A”. Repeat-A consists of eight to nine tandemly arrayed, 50 nucleotide long repeating elements 
that each harbor a degenerate U-rich region followed by a GC-rich region that is highly 
conserved among eutherians (18,19). Overexpressed Xist cDNA transgenes lacking Repeat-A 
accumulate around the mouse embryonic stem cell (ESC) inactive X chromosome in wild-type-
like patterns, but they are incapable of silencing gene expression. Repressive function of the 
                                                 
1This chapter is an article currently in press at Nucleic Acids Research. The original citation is as follows: 
Lee, D.M., Trotman, J.B., Cherney, R.E., Inoue, K., Schertzer, M.D., Bischoff, S.R., Cowley, D.O. and 
Calabrese, J.M. (2019) A 5′ fragment of Xist can sequester RNA produced from adjacent genes on 
chromatin. Nucleic Acids Research. doi: 10.1093/nar/gkz432. 
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mutant transgenes can be restored by appending Repeat-A or synthetic, Repeat-A-like sequences 
to their 3′ ends, demonstrating that Repeat-A functions as a self-contained module necessary to 
confer gene silencing activity to Xist (40-42). 
Repeat-A is thought to induce gene silencing by recruiting the protein SPEN. Knockout 
or knockdown of SPEN in multiple experimental contexts results in failure of XCI, establishing 
SPEN as an essential Xist cofactor (13,22,24,25). In transgenic Xist cDNA overexpression 
experiments, Repeat-A is necessary to recruit SPEN to Xist (13). Concordantly, in vivo, iCLIP 
demonstrates robust association between SPEN and Repeat-A, and in vitro, SPEN associates 
with single-stranded, U-rich regions of Repeat-A that are located directly adjacent to its 
structured, GC-rich segments (35,43). In contexts outside of XCI, SPEN has been shown to 
repress transcription of target genes through its association with SMRT/NCoR and NuRD co-
repressor complexes and several histone deacetylases (HDACs; (26-28)). Transient knockdown 
of SMRT and HDAC3 in male and in female ESCs reduces the efficacy of Xist-induced gene 
silencing, providing support for the notion that during XCI, SPEN silences gene expression by 
recruiting co-repressors to Xist (22). 
Despite clear links between SPEN and Repeat-A, questions remain regarding the 
mechanism through which Repeat-A functions. Most notably, while SPEN is necessary for XCI, 
it is not known if SPEN binding to Repeat-A is sufficient to induce transcriptional silencing (22). 
Moreover, outside of transgenic contexts, deletion of Repeat-A from the endogenous Xist locus 
causes not only a failure of XCI, but the destabilization of Xist itself (44,45). The mechanisms by 
which Repeat-A promotes Xist stability are unclear. Lastly, in transgenic Xist cDNA 
overexpression experiments, Repeat-A appears to be involved in targeting Xist to actively 
transcribed regions (46,47). How Repeat-A is involved in this targeting is unclear. It has been 
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noted that the mechanism is difficult to disentangle from Repeat-A-mediated stabilization of Xist 
(48). 
We recently developed a transgenic assay that recapitulates Repeat-A-dependent gene 
silencing, which we called TETRIS (Transposable Element to Test RNA’s effect on transcription 
in cis; (49)). In the assay, expression of the first 2 kilobases (kb) of Xist (Xist-2kb), which 
contains Repeat-A, is driven by a doxycycline-inducible promoter positioned adjacent to a 
constitutively expressed luciferase reporter gene. The linked Xist-2kb and luciferase genes are 
inserted into the genomes of ESCs using the piggyBac transposase. Addition of doxycycline to 
the media induces expression of Xist-2kb and results in an 80-90% reduction of luciferase 
activity relative to cells that did not receive doxycycline. We demonstrated that repression of 
luciferase by Xist-2kb in TETRIS requires the same sequence motifs within Repeat-A that are 
required for transcriptional repression by full-length Xist – the GC-rich portion of Repeat-A but 
not its U-rich spacer sequences, as well as three adjacent structured elements and their 
intervening sequences (38,40,49,50).  
Given questions surrounding the mechanisms through which Repeat-A functions in Xist, 
we sought to investigate the mechanism of repression induced by Xist-2kb in TETRIS as well as 
in a transgenic, single-copy insertion assay that is analogous to transgenic assays previously 
employed in mouse ESCs to identify seminal aspects of Xist biology (13,14,22,24,25,40-42,46). 
We found, quite surprisingly, that Xist-2kb represses gene expression not at the transcriptional 
level, but by sequestering the mRNA of neighboring genes on chromatin. To our knowledge, our 
study is the first to demonstrate that expression of a lncRNA can block the nuclear export of 
RNA produced from an adjacent gene. We demonstrate that the ability to sequester RNA on 
chromatin is not unique to Xist-2kb but can also be induced by the expression of Xist-like, 
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synthetic lncRNAs and by hypomorphic Xist mutants that retain Repeat-A but lack other key 
silencing domains. Furthermore, we show that recapitulating an interaction between SPEN and 
Repeat-A on chromatin is insufficient to induce local transcriptional silencing. Thus, in mouse 
ESCs, Repeat-A is necessary but not sufficient for Xist-induced transcriptional silencing. Instead, 
Xist-induced transcriptional silencing requires synergy between Repeat-A and other regions of 
Xist. We hypothesize that the mechanisms that underpin sequestration are relevant to the 
stabilization of Xist by Repeat-A and its role in recruiting Xist to actively transcribed regions of 
chromatin. 
2.2 Results 
2.2.1 Xist-2kb sequesters mRNA on chromatin 
TETRIS is a transgenic assay that allows the sequence of a lncRNA to be manipulated in 
a plasmid and then tested for its ability to repress activity of an adjacent reporter gene in a 
chromatin context. The assay employs the piggyBac transposase to insert a lncRNA expression 
cassette, a luciferase gene, and a gene conferring resistance to puromycin into the genomes of 
transfected cells (Figure 2.1A). Expression of non-repressive lncRNAs in the assay typically 
causes a ~2-fold increase in luciferase activity, which we attribute to the proximity of the 
doxycycline-inducible TRE promoter and the PGK promoter that drives expression of luciferase 
(49). In contrast, we previously demonstrated that expression of the first 2kb of Xist (Xist-2kb) in 
TETRIS causes an 80 to 90% reduction of luciferase activity; this silencing depends on Repeat-A 
and an additional ~750 nucleotides of sequence located just downstream (region deleted in 
Δss234 in Supp Figure 2.1A; (49)).  
During our initial validation of TETRIS, we performed a control to verify that expression 
of Xist-2kb caused a level of transcriptional silencing commensurate with the 80% reduction in 
luciferase protein activity. To our surprise, Xist-2kb expression led to an increase, not decrease, 
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in luciferase mRNA levels, despite the repression of luciferase protein activity (Figure 2.1B, C). 
The decrease in luciferase protein was confirmed by western blot (Supp Figure 2.1B), while the 
increase in luciferase mRNA abundance was characteristic of TETRIS assays in which non-
repressive lncRNAs are expressed (see Hottip assays in Figure 2.1B and C and (49)). The 
concurrent 80% reduction of luciferase protein activity and elevation of luciferase mRNA levels 
persisted even after 21 days of Xist-2kb induction (data not shown). Strand-specific RT-qPCR 
assays confirmed that the increase in luciferase mRNA originated from the PGK promoter 
driving luciferase and not from a long, read-through transcript originating from the TRE 
promoter (Figure 2.1D). 
We hypothesized that the reduced level of luciferase activity without loss in mRNA 
abundance was due to physical sequestration of the luciferase mRNA on chromatin. We 
fractionated cells as in (51,52) and found that upon Xist-2kb induction, the vast majority of total 
luciferase mRNA co-purified with chromatin, consistent with our hypothesis (Figure 2.2A). 
Malat1 RNA and Gapdh mRNA showed no change in distribution after Xist-2kb induction, as 
expected (Figure 2.2A).  
The percentage of mRNA that co-purified with chromatin from the puromycin resistance 
gene (PuroR) also increased upon Xist-2kb induction (Figure 2.2A), and the functional 
consequence of PuroR mRNA sequestration was confirmed by observations that Xist-2kb 
expression inhibited the survival of cells grown in the presence of puromycin (Supp Figure 
2.1C). In contrast to the luciferase gene, which is convergently oriented relative to Xist-2kb, the 
PuroR gene is oriented in tandem. Collectively, these results demonstrate that sequestration 
induced by Xist-2kb is not exclusive to the luciferase mRNA and show that sequestration can 
occur regardless of whether target genes are oriented in tandem or convergently to the inducing 
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lncRNA. We also observed a full recovery of luciferase activity after two days growth in the 
absence of doxycycline, demonstrating that sequestration requires continued expression of Xist-
2kb (Figure 2.2B). 
The sequestration of luciferase and PuroR mRNAs was accompanied by changes in 
mRNA stability. Upon expression of Xist-2kb, the half-life of luciferase mRNA dropped ~75%, 
from 14.9 hours to 3.9 hours, and the half-life of PuroR mRNA dropped ~50%, from 17 hours to 
8.2 hours (Figure 2.2C). Expression of Hottip had no effect on the stability of luciferase or 
PuroR mRNA (Figure 2.2C).  Translation is thought to be a major mechanism through which 
mRNAs are stabilized in cells (53), so the reduced half-lives are consistent with a shift of 
luciferase and PuroR mRNA to the chromatin fraction upon expression of Xist-2kb.  
It was unclear whether partial or full-length luciferase and PuroR mRNAs were 
sequestered in the nucleus upon Xist-2kb expression. Using RT-qPCR with primer pairs targeting 
multiple regions of each mRNA, we found that Xist-2kb expression caused changes in signal 
along the length of luciferase and PuroR mRNAs that were similar between primer pairs (Figure 
2.2D-F). Upon induction of Xist-2kb, cytoplasmic levels of luciferase mRNA decreased three- to 
four-fold, coincident with the observed four- to seven-fold increases in nuclear signals (Figure 
2.2E). Relatedly, cytoplasmic levels of PuroR mRNA decreased six- to eight-fold upon Xist-2kb 
expression, while the nuclear levels of PuroR remained unchanged (Figure 2.2F). The exception 
to these patterns was a twelve- and four-fold increase in nuclear signal at the 5′ ends of the 
luciferase and PuroR transcripts, respectively, which may be consistent with the accumulation of 
short 5′ mRNA products via an increase in promoter-proximal pausing upon addition of 
doxycycline (Figure 2.2E, F; (54)). We also note that the apparent increase in overall levels of 
luciferase mRNA were only detected when the ‘Luc 4’ primer pair was used (Figure 2.2E; Figure 
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2.1C luciferase data were also obtained using the ‘Luc 4’ primer pair). Taken together, these data 
suggest that although full-length luciferase and PuroR mRNAs are still produced in the presence 
of Xist-2kb, their export to the cytoplasm is greatly hindered.  
We hypothesized that luciferase mRNA was specifically sequestered near the site of Xist-
2kb transcription. To test this hypothesis, we used a single-molecule sensitivity FISH assay from 
Stellaris (55). In Xist-2kb ESCs untreated with doxycycline, luciferase mRNA was broadly 
dispersed throughout the cytoplasm, consistent with its ongoing export from the nucleus and 
active translation (Figure 2.2G). In contrast, upon Xist-2kb induction, the cytoplasmic signal was 
lost, and we observed the appearance of foci of luciferase mRNA that co-localized with Xist-2kb 
in the nucleus. These results suggest that sequestration occurs in cis, in regions that accumulate 
Xist-2kb upon addition of doxycycline (Figure 2.2G). 
2.2.2 Sequestration depends on GC-rich sequence elements in Repeat-A and can be induced 
by Xist-like, synthetic lncRNAs 
In previous work, we demonstrated that repression of luciferase by Xist-2kb in TETRIS 
depended specifically on the GC-rich individual repeats in Repeat-A, and not its U-rich spacers, 
as well as three stably structured elements located just downstream of Repeat-A and their 
intervening sequence ((49); Figure 2.3A). Consistent with these data, we found that deletion of 
the GC-rich portions of Repeat-A, the stably structured region, or all of Repeat-A and the 
downstream structures each abrogated sequestration of luciferase and PuroR mRNA (∆rA (no 
GC), ∆ss234, and ∆rA234, respectively; Figure 2.3A, B). Relative to Xist-2kb, these deletions 
led to an apparent destabilization of the mutant Xist transcripts coincident with a minor reduction 
in their association with chromatin (Figure 2.3C, D). Collectively, these data show that the same 
genetic elements in Repeat-A that are required for repression by full-length Xist (40) are required 
for sequestration of luciferase mRNA. 
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We recently recognized that different lncRNAs can encode similar function through 
different spatial arrangements of related sequence motifs (49). As a part of that study, we 
designed a series of synthetic lncRNAs with varying levels of non-linear sequence similarity to 
Xist-2kb, and we demonstrated using the TETRIS assay that the synthetic lncRNAs repressed 
luciferase activity in a manner that was directly proportional to their non-linear similarity to Xist-
2kb. The synthetic lncRNAs had no linear homology to Xist, each other, or any region in the 
mouse or human genome (49). Here, we examined whether these synthetic lncRNAs, like Xist-
2kb, repressed luciferase activity in TETRIS by sequestering mRNA on chromatin. Indeed, we 
observed a direct correlation between the repressive activity of synthetic lncRNAs in TETRIS 
(Figure 2.3E) and their ability to sequester luciferase mRNA on chromatin (Figure 2.3F). Thus, 
in addition to Xist, other lncRNAs are also capable of sequestering nearby mRNA on chromatin. 
Further, their ability to sequester nearby mRNA is correlated to their non-linear sequence 
similarity to Xist-2kb. 
2.2.3 Xist hypomorphs sequester nearby mRNA on chromatin as single-copy insertions 
Under the conditions we use to make standard TETRIS ESC lines, approximately five 
copies of the Xist-2kb/luciferase cargo DNA are randomly inserted into the genome of each cell 
that survives the selection process (49). We sought to determine if Xist-2kb could sequester the 
mRNA of nearby genes when inserted as a single copy into a defined chromosomal locus. 
Insertion into a defined locus would also allow us to determine the extent to which Xist-induced 
sequestration can spread along a single chromosome. In parallel, such a system would allow us 
to directly compare the extent to which Xist-2kb silenced gene expression relative to full-length 
Xist as well as to hypomorphic Xist mutants that lacked different subsets of key functional 
domains. 
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To these ends, we established a recombinase-mediated cassette exchange (RMCE) 
system in the Rosa26 locus (56). We created a Rosa26 targeting vector that contained a lox66 
site, a puromycin-Herpes-Simplex-Virus-thymidine-kinase fusion protein, and a lox2272 site 
followed by a polyadenylation cassette (Supp Figure 2.2A). The targeting construct was 
electroporated into F1-hybrid, male ESCs that were derived from a cross between C57BL/6J 
(B6) and CAST/EiJ (Cast) mice, and Southern blot was used to confirm insertion of the construct 
into the correct locus on the B6 allele of selected clones (Supp Figure 2.2B). In parallel, we 
created a cargo vector that contained a lox71 site, a lncRNA-expression cassette driven by a 
doxycycline-inducible promoter, a constitutively expressed hygromycin B resistance gene 
lacking a polyadenylation signal, and a lox2272 site (Supp Figure 2.2C). Electroporation of the 
cargo vector along with Cre recombinase into our F1-hybrid RMCE cells, followed by positive 
selection on hygromycin B and negative selection on ganciclovir, generates a small number of 
surviving clones that harbor cargo vectors inserted in the desired orientation in Rosa26 (Supp 
Figure 2.2D; not shown). 
We employed this RMCE system to create four separate ESC lines that expressed 
different versions of inducible Xist transgenes from Rosa26 (Figure 2.4A): one line expressed the 
Xist-2kb transgene, another line expressed full-length Xist from its endogenous DNA sequence 
(not a spliced transgene), another line expressed the first 5.5kb of Xist (‘Xist-5.5kb’), which 
includes the Repeat-B and Repeat-C domains of Xist known to recruit PRC1 (14), and a final line 
expressed Xist-2kb fused to the final 2 exons of Xist (‘Xist-2kb+6,7’). The final two exons of Xist 
include Repeat-E and are essential for proper Xist localization and PRC2 recruitment to the 
inactive X (15,16,57). As a negative control, we created a control ESC line that underwent 
recombination but lacked any Xist insertion (“empty”). We then used piggyBac-mediated 
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transgenesis to insert the reverse-tetracycline transactivator (rtTA; (58)) into select clones of each 
genotype, to allow doxycycline-inducible expression of each cargo RNA. RNA FISH and RT-
qPCR verified the doxycycline-inducible expression of each transgene in each clone (Figure 
2.4B and not shown). We note that despite several attempts, we were unable to clone an Xist-
5.5kb construct that contained all ~36 repeats in Repeat-B; the construct used for this study 
contained ~14 repeats (Figure 2.4A and Supp Figure 2.3A). 
To determine if any of the Xist sequences sequester nearby mRNAs when expressed from 
the Rosa26 locus, and to determine how far along the chromosome the sequestration spread, we 
induced Xist transgene expression for three days and sequenced RNA purified from cytoplasmic 
and nuclear fractions. In parallel, we treated empty-cargo ESCs with doxycycline for three days 
and sequenced RNA purified from cytoplasmic and nuclear fractions. Expression of the Xist 
transgenes was verified by examining reads mapping to the endogenous Xist locus (which is not 
expressed in these cells; Supp Figure 2.3B), and total counts were used to calculate RPKM 
values for each Xist transgene. All transgene RNA localized in the nucleus (Supp Figure 2.3C), 
and expression levels were only slightly lower for the Xist hypomorphs than for full-length Xist 
(Figure 2.4C). 
Next, we examined the extent to which cytoplasmic gene expression was silenced by the 
different Xist transgenes (Supp Figure 2.4A-H). In cells expressing full-length Xist, we detected 
2404 genes that were differentially expressed between empty-cargo ESCs after three days of 
doxycycline treatment. On the B6 allele of chr6 – the chromosome that harbors the Xist 
transgene at the Rosa26 locus – 214 genes were differentially expressed (Supp Figure 2.4A). Of 
these, 205 genes shifted in the downward direction and 9 shifted in the upward direction, 
consistent with repression by full-length Xist (Supp Figure 2.4A). On the Cast allele of chr6, only 
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34 genes changed, with similar numbers going up (21) and down (13; Supp Figure 2.4B). The 
2175 remaining differentially expressed genes throughout the genome also consisted of similar 
numbers of genes that were up- and down-regulated (1012 and 1163, respectively). Thus, as 
expected, insertion of full-length Xist into Rosa26 caused chromosome-level repression of genes 
in cis, and also caused gene expression changes genome-wide due to secondary effects of Xist 
expression. 
Expression of Xist-5.5kb and Xist-2kb+6,7 also led to silencing of genes along the B6 
allele of chr6, but at a reduced level relative to full-length Xist. Xist-5.5kb expression led to 
differential expression of 98 genes on the B6 allele of chr6, 76 of which were shifted down 
(Supp Figure 2.4C; Cast allele Supp Figure 2.4D). Xist-2kb+6,7 expression led to differential 
expression of 88 genes on the B6 allele of chr6, 65 of which were shifted down (Supp Figure 
2.4E; Cast allele Supp Figure 2.4F). The majority of genes repressed by the two hypomorphs 
were also repressed by full-length Xist (69 of 76 for Xist-5.5kb and 64 of 65 for Xist-2kb+6,7). 
Forty-nine genes were silenced by all three transgenes (Figure 2.4D). The loss of nuclear as well 
as cytoplasmic RNA-seq signal at these genes indicated that, along with full-length Xist, the 
hypomorphic Xist transgenes induced transcriptional silencing (Supp Figure 2.5A-C).  
In contrast, when comparing cytoplasmic expression between Xist-2kb and empty-cargo 
ESCs, we only detected 3 differentially expressed genes genome-wide (including Xist), all on the 
B6 allele of chr6 (Supp Figure 2.4G; Cast allele Supp Figure 2.4H). These data indicate that 
expression of Xist-2kb does not cause chromosome-level changes in gene expression.  
However, when we examined cytoplasmic and nuclear levels of the two genes nearest to 
the transgene insertion site – the gene conferring hygromycin resistance (~1kb downstream; 
HygroR), and Setd5 (~5kb downstream) – we found strong evidence of Xist-induced 
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sequestration, specifically in cells expressing Xist hypomorphic transgenes. The nuclear fraction 
of reads deriving from HygroR was significantly increased by expression of Xist-2kb, Xist-5.5kb, 
and Xist-2kb+6,7, but not by full-length Xist (Figure 2.4E), consistent with sequestration of 
HygroR mRNA. Similarly, the nuclear fraction of reads mapping to the B6 allele of the Setd5 
gene was significantly increased by expression of Xist-2kb and Xist-5.5kb, but not by Xist-
2kb+6,7 or full-length Xist (Figure 2.4F). Single-molecule FISH confirmed that HygroR mRNA 
co-localized in the nucleus with Xist-2kb, providing additional support that sequestration occurs 
in cis, near the site of Xist transcription (Figure 2.4G). Examination of nuclear RNA levels 
relative to empty-cargo control indicated that in Xist-2kb and Xist-5.5kb cells, sequestration of 
HygroR and Setd5 was not accompanied by transcriptional silencing (Figure 2.4H, I). In contrast, 
the same analysis showed that in Xist-2kb+6,7 cells, sequestration of HygroR occurred jointly 
with transcriptional silencing (Figure 2.4H). Sequestration remained limited to the genes 
adjacent to the Xist-insertion locus; we found no evidence for sequestration of genes along the 
rest of chr6 (Supp Figure 2.5D and not shown). 
Next, we used RT-qPCR to determine if sequestration was accompanied by a change in 
total levels of mRNA produced from sequestered genes. Indeed, relative to empty-cargo control, 
total mRNA levels of HygroR were decreased by more than 70% by all Xist hypomorphs that 
induced HygroR sequestration (Xist-2kb, Xist-5.5kb, and Xist-2kb+6,7; Figure 2.4J). Total 
mRNA levels of Setd5 were also modestly decreased by one of two Xist hypomorphs that 
induced Setd5 sequestration (decreased by Xist-2kb but not by Xist-5.5kb; Figure 2.4K). 
Consistent with these results, expression of Xist-2kb in TETRIS led to an overall reduction in 
PuroR mRNA levels (Figure 2.2F) and significantly reduced luciferase and PuroR mRNA 
stability (Figure 2.2C). Together, these results indicate that sequestration can decrease total 
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levels of mRNA without causing transcriptional silencing, presumably because mRNA is 
degraded at a higher rate in the nucleus compared to the cytoplasm.  
We conclude that hypomorphic versions of Xist can sequester nearby mRNAs when 
expressed from a single chromosomal locus, that full-length Xist does not sequester mRNAs to a 
similar extent, and that sequestration remains local and can reduce mRNA levels of target genes. 
2.2.4 Lack of evidence for stable mRNA sequestration at the onset of X-inactivation 
It remained possible that sequestration of target mRNAs by full-length Xist occurred 
transiently, at the earliest stages of Xist-induced gene silencing, and was not detectable after 
three days of Xist induction. To test this idea, we sequenced cytoplasmic and nuclear RNA three, 
five, and 24 hours after induction of Xist in pSM33 cells, a male ESC line in which the 
endogenous promoter of Xist has been replaced with a doxycycline-inducible one (46). We found 
that 291 out of 421 expressed genes on the X were significantly silenced following 24 hours of 
Xist expression in pSM33 cells (Supp Figure 2.6A). However, we were unable to detect evidence 
for chromosome-level sequestration at any time-point post-Xist induction (Supp Figure 2.6B, C). 
Thus, at the time-points profiled, gene silencing by full-length Xist does not appear to be 
accompanied by the stable sequestration of mRNA on chromatin. 
2.2.5 Xist-2kb associates with SPEN and RBM15, but neither are required for sequestration 
Having established that expression of Xist-2kb in mouse ESCs does not induce 
transcriptional silencing, as would have been expected based on current models for Repeat-A 
function, we next sought to determine if Xist-2kb still bound SPEN, a key cofactor required for 
Repeat-A-induced transcriptional silencing (13,22,24,25). We also examined whether Xist-2kb 
bound RBM15, another Repeat-A binding protein shown to be important for Xist-induced 
silencing (24,33). We used a formaldehyde-based immunoprecipitation (IP) approach to 
determine whether SPEN and RBM15 associated with the Xist-2kb RNA (59). Indeed, IP of both 
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SPEN and RBM15 from crosslinked and sonicated cell extracts robustly retrieved RNA 
corresponding to Repeat-A, but did not retrieve RNA upstream or downstream of Repeat-A 
within Xist-2kb. The enrichment of Repeat-A was lost in IP from ∆rA234 cells (Figure 2.3A and 
Figure 2.5A, B). Thus, two Repeat-A binding proteins required for Xist-induced transcriptional 
silencing, SPEN and RBM15, also associate with Xist-2kb in a Repeat-A-dependent manner. 
To determine whether Xist-induced sequestration requires SPEN or RBM15, TETRIS 
assays using Xist-2kb were performed in ESCs following CRISPR-mediated deletion (SPEN) or 
depletion (RBM15) of the proteins. For SPEN, ~40kb of the gene, including its major RNA-
binding domains (43), was targeted for deletion by CRISPR (Supp Figure 2.7A). This deletion is 
known to cause complete failure of XCI and is expected to comprise a null mutant (25). Deletion 
was confirmed in select clones by PCR of genomic DNA and RT-qPCR (Supp Figure 2.7B and 
Figure 2.5C), which showed the expected loss of Spen mRNA expression in the deleted region. 
TETRIS assays performed in two independent SPEN deletion lines showed that SPEN deletion 
had no effect on Xist-induced sequestration (Figure 2.5D). For RBM15, polyclonal cell 
populations were generated that carried sgRNAs targeting a doxycycline-inducible Cas9 to 
numerous locations in gene exons of Rbm15, leading to significant depletion of the protein 
product (Figure 2.5E, Supp Figure 2.7C). RBM15B, a paralog of RBM15 which can compensate 
for its role in Xist-mediated repression (33), was also depleted individually and in combination 
with RBM15 (Figure 2.5E, Supp Figure 2.7D). EZH2, which we did not expect to be involved in 
Xist-induced sequestration, was also depleted as a negative control (Figure 2.5E, Supp Figure 
2.7E). As a second control, we performed TETRIS assays in cells which express Cas9, rtTA, and 
a sgRNA that lacked a genic targeting sequence (rtTA, Figure 2.5E). Relative to control cells that 
expressed the non-targeting sgRNA, TETRIS assays in knockdown cell lines showed no 
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reduction of luciferase protein repression (Figure 2.5F). Thus, individual knockdown of several 
proteins required for transcriptional silencing by Xist – SPEN, RBM15, RBM15B, and EZH2 – 
does not affect silencing of luciferase in TETRIS. 
2.3 Discussion 
Reductionist systems are ubiquitously employed in biology to simplify complex systems 
into constituent parts. Such systems have fundamentally advanced our understanding of many 
biological processes, including transcription, splicing, and epigenetic phenomena such as 
position effect variegation and XCI. Using two reductionist assays similar in nature to those that 
have been used in many prior studies in mouse ESCs to identify seminal aspects of Xist biology 
(13,14,22,24,25,40-42,46), we found, quite unexpectedly, that expression of the first 2kb of Xist 
was insufficient to induce transcriptional silencing of nearby genes. Instead, Xist-2kb silenced 
adjacent genes at the post-transcriptional level, by sequestering their RNA on chromatin. 
Sequestration was rapidly reversible upon loss of Xist-2kb expression, and, critically, depended 
on the same sequences within Repeat-A that are needed to induce transcriptional silencing by 
full-length Xist: its conserved, GC-rich segments, but not its intervening U-rich spacers (Figure 
2.1 and Figure 2.2; (40)). Sequestration of RNAs produced from genes located at variable 
distances and in different orientations relative to Xist-2kb, as well as the lack of sequestration in 
cells expressing Hottip or empty-cargo control RNAs, indicates that sequestration is not an effect 
of convergent transcription. Our ability to observe sequestration of multiple target RNAs by Xist-
2kb, as well as sequestration of a single target RNA by multiple synthetic lncRNAs, indicates 
that sequestration is unlikely to require extensive base pairing between lncRNA and target and 
supports its dependence on a protein intermediary. In the context of the Rosa26 locus, there was 
not a clear relationship between sequestration and expression levels of Xist transgenes. 
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Knockdown of our top candidates, SPEN and RBM15, had no effect on sequestration, suggesting 
the process may be mediated by other proteins.  
We found no evidence of ongoing sequestration at time points both early and late after 
induction of full-length Xist, but we did observe local sequestration by two Xist hypomorphs that 
were capable of chromosome-scale transcriptional silencing. These data suggest that stable 
sequestration of target genes is not an obligate intermediate during Xist-induced gene silencing. 
However, along with our experiments done with synthetic lncRNAs, they indicate that 
sequestration is not an action limited to Xist-2kb.  
Our study provides another example of a connection between lncRNAs and pathways that 
mediate the export of RNA from the nucleus. For reasons that are unclear, many of the proteins 
that Xist requires for its function have roles in RNA export (24). Moreover, the lncRNAs Malat1 
and Neat1 have been shown to sequester RNAs in specific regions of the nucleus, and, 
intriguingly, at the level of k-mers, Malat1 and Neat1 are more similar to Xist than they are 
similar to most other lncRNAs (49,60-62). A recent study found that release of a lncRNA from 
chromatin coincided with increased transcription from a nearby protein-coding gene (63). Thus, 
in the mammalian nucleus, multiple connections exist between lncRNAs, RNA export, and 
transcription.  These connections extend even to the fission yeast Schizosaccharomyces pombe, 
where a block in RNA export during meiosis induces locus-specific formation of 
heterochromatin (64). 
Thus, in ways that are not yet understood, it is conceivable that Xist functions in part by 
interfering with RNA export.  It is possible that sequestration of RNA occurs during the earliest 
phases of Xist-induced gene silencing, but that sequestration is undetectable under steady-state 
conditions because it destabilizes RNA and is followed immediately by transcriptional silencing. 
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Consistent with this notion, sequestration was only apparent upon expression of Xist mutants 
with attenuated silencing capabilities, and sequestration reduced overall levels of target 
transcripts. In TETRIS, Xist-2kb reduced the total levels of PuroR mRNA by four-fold without 
changing its nuclear levels, and Xist-2kb also reduced the stability of luciferase and PuroR 
mRNA (Figure 2.2F, C). Similarly, in the Rosa26 locus, Xist-2kb and Xist-5.5kb reduced total 
levels of HygroR mRNA by five-fold without reducing nuclear levels (Figure 2.4J, H). A 
separate study, performed in human cells, found that as few as two individual monomers from 
Repeat-A were sufficient to reduce the total mRNA levels of a nearby GFP reporter by half (65). 
While this reduction in GFP mRNA was interpreted as transcriptional silencing, the decrease 
could have been due to a Repeat-A induced block in nuclear export leading to destabilization of 
GFP mRNA. Together, these examples are not inconsistent with the possibility that a block in 
nuclear export of target genes (i.e. sequestration) occurs transiently during XCI, coincident with 
the onset of Xist-induced transcriptional silencing. Sequestration would reduce overall levels of 
mRNA from sequestered genes, and would be difficult to distinguish from transcriptional 
silencing unless RNA localization or half-life was analyzed at the appropriate time-point. 
However, because expression of Xist-2kb was not associated with transcriptional 
silencing, nor did sequestration require the critical silencing factor SPEN, nor did sequestration 
spread beyond genes that were directly adjacent to hypomorphic Xist insertion sites, we favor the 
hypothesis that the mechanisms that underlie sequestration are more directly related to the 
splicing, post-transcriptional stabilization, and/or localization of Xist to actively transcribed 
regions of chromatin. All of these events, as well as sequestration, depend on a functional 
Repeat-A element (44-47). It is possible that the same proteins that cause Repeat-A to sequester 
nearby RNA on chromatin help tether Xist to actively transcribed loci through interactions with 
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RNAs produced from soon-to-be-repressed genes. Simultaneously or independently, the proteins 
required for sequestration may protect the unusually large exons in Xist (>7.5kb) from 
unintended splicing or degradation. Studies to address these hypotheses are ongoing in our 
laboratory. 
Finally, in the simplest model for XCI, Xist recruits SPEN via Repeat-A, which, in turn, 
recruits HDAC3 to silence transcription over the X chromosome (22). Our data definitively 
demonstrate that in mouse ESCs, recapitulating a SPEN/Repeat-A interaction is insufficient to 
induce transcriptional silencing by Xist, highlighting a critical gap in our understanding of the 
mechanism through which Repeat-A functions to silence gene expression. Even though Xist-2kb 
is retained on chromatin and binds SPEN in Repeat-A-dependent fashion, it fails to induce 
transcriptional silencing, even of nearby genes. However, fusion of Xist-2kb to the remaining 
first 5.5kb of Xist, which in our construct included Repeat-C and a portion of the essential PRC1 
recruitment  domain Repeat-B (Figure 2.4A, Supp Figure 2.3A; (14)), or the fusion of Xist-2kb 
with the final two exons of Xist, which lacks a PRC1 recruitment domain but contains Repeat-E 
and additional downstream sequence elements (15,16,38,57), both conferred near-equal 
transcriptional silencing capability in an isogenic context (Figure 2.4, Supp Figure 2.3, and Supp 
Figure 2.4). Thus, in mouse ESCs, Repeat-A is necessary for Xist-induced transcriptional 
silencing, but it is not sufficient. Silencing requires synergy between Repeat-A and additional 
downstream sequence elements within Xist. It will be important to define the molecular 
mechanisms that underlie this synergy in future works. 
More broadly, the potential for similar forms of synergy between protein interaction 
modules in RNA is widespread in the mammalian transcriptome. For example, many of the 
proteins that Xist binds in cells are considered to be “splicing factors” that have well-documented 
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roles in RNA processing and export (13,14,22,23,45). The Xist cofactor HNRNPK binds 
thousands of different positions within thousands of RNA transcripts yet only a subset of the 
binding events are directly associated with changes in splicing (66,67). Still, we presume that 
HNRNPK binding in its own capacity is not sufficient to cause transcripts to induce Xist-like 
gene silencing. Similarly, SPEN family proteins are known to be involved in the nuclear export 
and 3´-end processing of mRNAs (68-71), and SPEN itself appears to associate with thousands 
of different transcripts in ESCs and in mouse trophoblast stem cells ((43,72); Supp Table 2.4; 
JMC unpublished).  Presumably, the majority of these associations do not cause Xist-like 
transcriptional silencing events. Understanding the properties that confer regulatory function to 
RNAs will require the study of their protein binding modules in isolation and in combination. 
2.4 Methods 
2.4.1 ESC culture 
E14 and pSM33 ESCs (kind gifts of D. Ciavatta and K. Plath, respectively) were grown 
on gelatin coated dishes at 37°C in a humidified incubator at 5% CO2.  Medium was changed 
daily and consisted of DMEM high glucose plus sodium pyruvate, 15% ESC qualified fetal 
bovine serum, 0.1 mM non-essential amino acids, 100 U/mL penicillin-streptomycin, 2 mM L-
glutamine, 0.1mM 2-mercaptoethanol, and 1:500 LIF conditioned media produced from Lif-1Cα 
(COS) cells (kind gift of N. Hathaway). ESCs were split at an approximate ratio of 1:6 every 
48hr. Rosa26-RMCE cells were grown on gamma-irradiated mouse embryonic fibroblast (MEF) 
feeder cells plated at approximately 1.5x10^6 cells per 10cm plate. Prior to harvesting of RNA 
for sequencing, Rosa26-RMCE cells were passaged twice off of MEF feeder cells with a 40-
minute pre-plate each passage and grown in 70% MEF-conditioned medium supplemented as 
above. 
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2.4.2 TETRIS line generation 
TETRIS lines were made as described in (49). Briefly, 4x10^5 E14 cells were seeded in a 
single well of a 6-well plate, and transfected 24hr later with 0.5µg TETRIS cargo, 0.5 µg rtTA-
cargo, and 1 µg of pUC19-piggyBAC transposase using Lipofectamine 3000 (Invitrogen) 
according to manufacturer instructions. Cells were selected for 7-9 days with puromycin (2 
µg/mL) and G418 (200 µg/mL) beginning 24hr after transfection. TETRIS cargo vectors were 
generated as part of (49). 
2.4.3 TETRIS assays 
For each independent TETRIS cell line, six wells of a 24-well plate were seeded at 
1x10^5 cells per well. Three of the six wells were induced with 1µg/mL doxycycline (Sigma) 
beginning when the cells were plated, and the remaining three wells served as “no dox” controls. 
After 48hr, the cells were washed with PBS and lysed with 100µL of passive lysis buffer 
(Promega) and luciferase activity was measured using Bright-Glo™ Luciferase Assay reagents 
(Promega) on a PHERAstar FS plate reader (BMG Labtech). Luciferase activity was normalized 
to total protein concentration in the lysates via Bradford assay (Bio-Rad). Data were plotted in 
Python (version 3.6.5) using the barplot function of Seaborn (version 0.8.1; 
https://doi.org/10.5281/zenodo.1313201) with default settings, including generation of 95% 
confidence intervals by 1000 iterations of bootstrap random sampling with replacement. 
2.4.4 RNA Isolation and RT-qPCR 
RNA was isolated using Trizol according to manufacturer protocol (Invitrogen) and 
quantified using a NanoDrop spectrophotometer (Thermo Scientific). RNA samples were 
periodically run on an agarose gel to assess RNA integrity. For RT-qPCR assays, equal amounts 
of RNA (200ng-2µg) were reverse transcribed in 10 or 20µL reactions using the High-Capacity 
cDNA Reverse Transcription Kit (Applied Biosystems) according to manufacturer protocol with 
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random primers or gene specific primers (Luc_qPCR4 in Supp Table 2.3). Control reactions 
without RT enzyme were periodically performed to assess DNA contamination. 
RT reactions were diluted 2- to 10-fold and 2µL was used in 10µL qPCR reactions with 
5µL iTaq Universal SYBR Green 2x Supermix (Bio-Rad) and custom primers at 150nM each 
(Supp Table 2.3). Prior to use, primer pairs were checked for specificity using the in silico PCR 
tool on the UCSC Genome Browser (http://genome.ucsc.edu/) and by analyzing melt curves on 
test qPCR reactions. qPCR was performed on a Bio-Rad CFX96 system with the following 
thermocycling parameters: initial denaturation at 95°C for 10min, 40 cycles of 95°C for 15sec, 
60°C for 30sec, and 72°C for 30sec followed by a plate read. Unless otherwise noted, technical 
duplicate qPCR measurements were made from single RT reactions. 
qPCR data were analyzed in CFX Manager Version 3.1.1517.0823 (Bio-Rad). Single-
threshold Cq determination was used, with manual adjustment of threshold if necessary to avoid 
background noise. Data were plotted in Python (version 3.6.5) using the barplot function of 
Seaborn (version 0.8.1; https://doi.org/10.5281/zenodo.1313201) with default settings, including 
generation of 95% confidence intervals by 1000 iterations of bootstrap random sampling with 
replacement. 
2.4.5 RNA fractionation 
To isolate RNA from cytosolic, soluble nuclear, and chromatin-bound fractions, cells 
were plated on 6-well or 12-well plates at an approximate density of 4x10^5 or 2x10^5 cells per 
well, respectively. Cells were induced with doxycycline at 1µg/mL (Rosa26-RMCE cells) or 
2µg/mL (pSM33 cells) for 3hr to 3d. For RNA harvest, all steps were performed at 4°C. Cells 
were washed twice with 1mL cold PBS, scraped in 1mL PBS, centrifuged at 1500xrcf for 5min, 
and resuspended in 250µL low salt solution (10mM KCl, 1.5mM MgCl2, 20mM Tris-HCl pH 
7.5) supplemented with 1mM PMSF, 1mM DTT, and 1:100 protease inhibitor cocktail (PIC; 
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Sigma P8340). Triton X-100 was added to a final concentration of 0.1% and cells were rotated 
for 10min, then centrifuged for 5min at 1500xrcf. 200µL of supernatant was added to 1mL Trizol 
(cytosolic fraction). The remaining supernatant was discarded and the nuclear pellet was washed 
by rotating for 2min in low salt solution without Triton X-100 and centrifuged at 1300rpm for 
10min. For RNA-seq experiments and the experiment in Figure 2.2D-F, nuclear pellets, which at 
this stage contained both soluble nuclear and chromatin-bound fractions, were resuspended in 
1mL Trizol. For all other qPCR experiments, nuclei were resuspended in 100µL Buffer B (3mM 
EDTA, 0.2mM EGTA) supplemented with 1mM DTT, 1mM PMSF, and 1x PIC, rotated for 
30min, and centrifuged at 1700xrcf for 10min. 100µL of supernatant was added to 1mL Trizol 
(soluble nuclear fraction). The chromatin pellet was washed by rotating for 2-5min in Buffer B 
and centrifuged at 1700xrcf for 10min. The pellet was resuspended in 1mL Trizol (chromatin-
bound fraction). Isolation of RNA from Trizol was performed according to manufacturer 
protocol. 
Equal amounts of RNA (200ng-1µg) were reverse transcribed using the High-Capacity 
cDNA Reverse Transcription Kit (Applied Biosystems) with random primers. qPCR was 
performed using iTaq Universal SYBR Green (Bio-Rad) and custom primers (Supp Table 2.3). 
For a given RNA species, log-transformed Cq values for each fraction were added together, and 
the percentage of total signal coming from each fraction along with propagated standard 
deviation was plotted in Python (version 3.6.5) using matplotlib (version 2.2.2; 
https://doi.org/10.5281/zenodo.1202077). For Figure 2.2D-F, relative abundances were 
calculated by fitting regression-determined Cq values to a standard curve using Bio-Rad CFX 
Maestro 1.1 software (version 4.1.2433.1219) and plotted using GraphPad Prism (version 8.0.0). 
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2.4.6 RNA stability assay 
E14 TETRIS Xist-2kb and Hottip cells were seeded at 1.2x10^5 cells per well of a 24-
well plate and grown overnight with or without doxycycline (1µg/mL). Doxycycline was 
removed and cells were treated with Actinomycin D (Sigma) at a concentration of 5µg/mL for 
0hr, 1hr, 2hr, 4hr, 8hr, and 12hr before adding Trizol and isolating RNA. Actinomycin D 
treatment and RNA isolation were performed on three independent platings of TETRIS Xist-2kb 
and Hottip cells for biological triplicates. Technical duplicate qPCR measurements were 
performed using iTaq Universal SYBR Green (Bio-Rad) and custom primers (Supp Table 2.3). 
Gapdh-normalized expression data for each replicate were set relative to the expression level of 
the 0hr timepoint. Data were plotted on a log2 scale in Python (version 3.6.5) using the lmplot 
function of Seaborn (version 0.8.1; https://doi.org/10.5281/zenodo.1313201) with default 
settings to draw a linear regression line with a 95% confidence interval. Linear regression 
models were made with the statsmodels package (version 0.9.0; 
http://conference.scipy.org/proceedings/scipy2010/pdfs/seabold.pdf) and used to determine half-
life values. To compare regression lines between uninduced and induced cells, a single linear 
regression model was built for each line and RNA species including an interaction term between 
time and induction (as a categorical variable) to test for a significant contribution of induction to 
stability. 
2.4.7 Puromycin sensitivity assay 
TETRIS cells expressing Xist-2kb were grown for 2 days with or without doxycycline 
(1µg/mL) before equal numbers of cells (5x10^5) were plated on 6-well plates in medium 
containing puromycin (2µg/mL) with or without doxycycline. Cells were trypsinized, mixed with 
trypan blue dye, and counted after 24hr and 48hr of puromycin treatment. Cell survival is shown 
relative to cells grown without doxycycline. Data were plotted in Python (version 3.6.5) using 
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the barplot function of Seaborn (version 0.8.1; https://doi.org/10.5281/zenodo.1313201) with 
default settings, including generation of 95% confidence intervals by 1000 iterations of bootstrap 
random sampling with replacement. 
2.4.8 Stellaris RNA FISH 
Custom Stellaris ® FISH probes were designed against the first 2kb of Xist, firefly 
luciferase (luc2 in pGL4.10; Promega), and the hygromycin resistance gene (HygroR) using the 
Stellaris® RNA FISH Probe Designer (Biosearch Technologies, Inc.) and labeled with Quasar ® 
670 (Xist-2kb) or 570 (luciferase and HygroR) dye. Cells were grown on glass coverslips for 2 
days in the presence or absence of 1µg/mL doxycycline before being washed once with 1x PBS, 
fixed for 10min at room temperature with 4% formaldehyde in 1x PBS, washed twice with 1x 
PBS, and permeabilized overnight with cold 75% ethanol at 4°C. 1µL of 2.5µM (Xist-2kb) or 
25µM (luciferase and HygroR) probe was added to 100µL of hybridization solution (10% 
dextran sulfate, 2x SSC, 10% formamide) and pre-warmed to 37°C. Coverslips were washed at 
37°C for 2-5min in pre-warmed wash buffer (2x SSC, 10% formamide). Coverslips were 
incubated with diluted probes overnight at 37°C in a humidified chamber, then washed twice 
with wash buffer at 37°C for 30min, adding DAPI to 5ng/mL for the second wash. Coverslips 
were rinsed with 2x SSC, mounted using Prolong Gold and allowed to cure overnight at room 
temperature or using Vectashield with nail polish sealing the edges. 
Four dimensional datasets were acquired by taking multi-channel Z-stacks on an 
Olympus BX61 widefield fluorescence microscope using a Plan-Aprochromat 63X/1.4 oil 
objective and a Hamamatsu ORCA R2 camera, controlled by Volocity 6.3 software. Excitation 
was provided by a mercury lamp and the following filters were used for the three fluorescent 
channels that were imaged: 377/25 ex, 447/30 em for DAPI (DAPI-5060B Semrock filter); 
562/20 ex, 642/20 em for Quasar 570 (Semrock TXRED-4040B filter); 628/20 ex, 692/20 em for 
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Quasar 670 (Semrock Cy5 4040A filter). Pixel size was 0.108 µm, Z spacing was 0.2 µm, and 
images had 1344x1024 pixels. Approximately 40 Z-stacks were acquired for each image. Z-
stacks were deconvolved using the iterative-constrained algorithm (Mediacy AutoQuantX3) with 
default algorithm settings. Sample settings for the deconvolution were: peak emissions for dyes 
(670 nm, 565 nm, 461 nm for Quasar 670, Quasar 570, and DAPI respectively), widefield 
microscopy mode, NA = 1.4, RI of oil = 1.518, and RI of sample = 1.45. Images are shown as 
maximum intensity projections made using ImageJ. 
2.4.9 Generation of the Rosa26 recombinase-mediated cassette exchange (RMCE) locus by 
homologous recombination 
A standard Rosa26 targeting vector was modified to make compatible for recombinase-
mediated cassette exchange (RMCE) by creating pR26-RMCE. Briefly, pRosa26-pA was 
digested with PacI and AscI to insert gene synthesis product SA-Stop-bGHpA-lox2272-mPGK-
PuroΔTK-lox66 (BioBasic Inc.). The gene synthesis product SA-Stop-bGHpA-lox2272-mPGK-
PuroΔTK-lox66 was released from the commercial vector by KpnI digest and was synthesized to 
contain 18-bp homologous ends for Gibson assembly into pRosa26-pA. Assembly was 
performed by mixing equimolar amounts of vector plus insert essentially as described above.  
The final targeting vector pR26-RMCE was sequence verified, linearized by KpnI, and 
2.5µL of 9,750ng/µL was nucleofected into approximately 1x10^6 cells of a male F1-hybrid 
mouse ESC line (derived from a cross between C57BL/6J (B6) and CAST/EiJ (Cast) mice; kind 
gift of T. Magnuson) using program CG-104 and the Amaxa 4D-nucleofector (V4XP-3024, 
Lonza). Prior to nucleofection, the ESC line was sent for karyotyping (Karyologic), which 
verified the 40N, XY nature of the cells. Nucleofected ESCs were plated on three 10cm plates 
containing gelatin and gamma-irradiated DR4 mouse embryonic fibroblasts (ASF-1015, Applied 
Stem Cell). Selection for a successful gene targeting event was performed 48hr after 
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nucleofection with 1µg/mL puromycin. Long-range PCR was used to screen for homologous 
recombination across the 3′ Rosa26 homology arm using 2.5µL mouse ESC lysate and the 
thermocycling program (95°C for 5 min, [98°C for 20 s, 63°C for 20 s, 72°C for 3 min; 40 
cycles] 72°C for 3 min, and 10°C soak) with primers (6238+, 6250-) (Supp Table 2.3). Two 96-
well plates were picked and 10 out of 188 colonies (~5.3%) were positive by long-range PCR. 
Genomic DNA was prepared from positive colonies as described in (73) with minor 
modifications. Briefly, colony DNA was enzymatically digested with 0.5mg/mL proteinase K 
in a tail lysis buffer containing the SDS detergent.  A saturated solution of sodium chloride 
was added to a final concentration of 25% v/v to salt out protein and centrifuged for 15min at 
10,000xrcf.  The genomic DNA remained in the supernatant and was transferred to a new tube 
for isopropanol precipitation, then washed in 70% ethanol to desalt. The DNA sample was 
resuspended in 150µL TE with low EDTA (10mM Tris, 0.1mM EDTA, pH 8.0) and allowed 
to solubilize overnight. 8-10µg of genomic DNA was digested at 37°C overnight with 50 U of 
MscI (R0534L, New England Biolabs). To ensure complete digestion of the genomic DNA, a 
pilot gel containing 0.7% agarose and TAE was run at 50V/cm to visualize MscI-cut genomic 
DNA that appeared as a smear with high-molecular banding. In cases were digestion was 
incomplete, the DNA was resuspended in 3 volumes of Buffer PB (Cat Nr. 19066, Qiagen) 
purified over a silica-column, washed with WS Buffer twice (Cat. Nr. B404-400, Epoch Life 
Science) and eluted in TE with low EDTA (10mM Tris, 0.1mM EDTA, pH 8.0).  The 
incompletely digested DNA was incubated 37°C overnight with 2-3µL containing 10-15 U of 
MscI in a 50µL reaction to completion.  A 15 x 10 cm Southern gel was cast with 0.7% TAE 
agarose and electrophoresed overnight at 20V/cm to achieve high resolution and efficient 
separation. The Southern gel was processed as follows:  depurination in 0.1M HCl for 10min, 
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denaturation twice in 0.1M NaOH for 15min, neutralization twice with 100mM Tris, 100mM 
NaCl pH 7.5 for 15min, and transferred to a wicking apparatus as described by (74) using 
20 × SSC to a 0.45μm microporous nylon 66 membrane on a polyester support, carrying 
positively charged quaternary ammonium groups (Cat. Nr. 11417240001, Roche). After 
approximately of 16-24hr of transfer, the wicking apparatus was deconstructed and the 
transferred DNA was crosslinked to the nylon membrane with 1200 joules of UV light for 
90sec.  The nylon membrane was blocked by an initial pre-hybridization step with 30-50mL 
of DIG Easy Hyb Granules (Cat. Nr. 1179689001, Roche) for 30min according to the 
manufacturer’s recommendation.  DIG-UTP labeled probes were denatured 5min at 70˚C and 
then immediately applied to pre-blocked nylon membrane in a rotisserie oven and hybridization 
continued overnight with constant agitation.  A low and high-stringency wash was performed at 
65 °C (2x SSC; 0.1% low-stringency, then 0.5 × SSC; 0.1% SDS high-stringency) for 30min. 
Membrane blocking and immunological detection used the DIG Wash and Block Buffer Set (Cat 
Nr. 11585762001, Roche) per the manufacture’s recommendations with 1:10,000 dilution of 
alkaline phosphatase-conjugated anti-DIG antibody and with 1:100 dilution of chemiluminescent 
substrate CDP-Star (Anti-digoxigenin-AP conjugate, Fab frag, Cat Nr. 11093274910; CDP-Star, 
Cat. Nr 11759051001, Roche).   Southern blotting probes were labeled by PCR with a dNTP mix 
containing 200µM dATP, dGTP, dCTP; 130µM dTTP and 14-70µM alkali-labile digoxigenin-
dUTP according to the manufacturer’s recommendations (PCR DIG Probe Synthesis Kit, Cat Nr. 
11636090910, Roche). Primers for probe synthesis are described in Supp Table 2.3. 
2.4.10 Construction of pCARGO-RMCE, pCARGO-RMCE containing the complete Xist 
genomic locus, pCARGO-RMCE-Xist-5.5kb, pCARGO-RMCE-Xist-2kb+6,7, and 
pCARGO-RMCE-Xist-2kb 
The base vector pCARGO-RMCE was constructed from pLCA.66/2272 and gene 
synthesis product lox71-TRE-CMV-mcs-SV40pA-FRT-mPGK-Em7-Hygro-FRT-lox2272 
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(BioBasic Inc.,).  The vector pLCA.66/2272 was a gift from M. Magnuson (Addgene plasmid # 
22733; (56)) and digested with AatII and XhoI.  The insert lox71-TRE-CMV-mcs-SV40pA-
FRT-mPGK-Em7-Hygro-FRT-lox2272 was digested with AatII and XhoI and had 18-bp 
compatible ends to vector pLCA.66/2272, and the insert cassette was subcloned by Gibson 
assembly. Assembly was performed by mixing equimolar amounts, e.g. 0.125pmol each, of 
vector plus insert in a final volume of 20µL with 2X assembly mix and incubating at 37°C for 
7:30, 50°C for 15min, 50°C for 1min where -1°C/cycle, n=10 cycles, 50°C for 35min, and final 
soak at 10°C. To make 2x assembly mastermix as modified from (75), the following reagents 
were prepared as follows: 6mL of 5x isothermal buffer (3mL 1M Tris, pH 7.5, 150µL 2M 
MgCl2, 600µL of 40mM lithium salt-dNTP mix, 300µL of 1M TCEP pH 7.5, 1.5g of PEG-8000, 
300µL of 100mM NAD, and Milli-Q water to 6mL).   The final 2x assembly mix was prepared 
to a volume of 600µL by addition of 240µL of 5x isothermal buffer, 2.4µL of 10 U/µL T5 FEN, 
15µL of 2 U/µL PfuX7, 120µL of 40 U/µL Taq DNA ligase, and Milli-Q water to 600µL (75). 
The pCARGO-RMCE-Xist-RFP capture vector was generated from pCARGO-RMCE by 
double digestion with MluI and SwaI and inserting PCR generated amplicons for Xist homology 
arms, BBa_292001, ccdB, and RFP into the vector by Gibson assembly using equimolar DNA 
parts of 0.125pmol each and transforming into Survival2 cells (A10460, ThermoFisher). The Xist 
5′ homology arm was 162 bp, and the 3′ homology arm was 416 bp. Sequence verification of 
multiple clones could not identify any clones with a functional ccdB, and the final vector 
contained a frameshifting ccdB deletion.  The red fluorescent protein mScarlet-I was functional 
and driven by the double terminator + constitutive promoter J23100 from BBa_292001. RFP was 
used for visual inspection of background transformants, e.g. red colonies, after recombineering. 
Plasmid DNA purified by the standard miniprep method of alkaline lysis with NaOH as 
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described originally by Birnboim and Doly, contains approximately 3% cyclic coiled DNA that 
is resistant to restriction digestion and leads to background transformants (76). The final capture 
vector pCARGO-RMCE-Xist-RFP was digested with PacI and gel extracted for retrieval of 
lncRNA Xist by gap repair.  
An Xist fosmid from the WIBR-1 mouse library (Mus musculus, female, strain 
C57BL/6J) corresponding to clone number WI1-2121K18 was obtained through BACPAC 
Resources. The original fosmid library was constructed by shearing genomic DNA and ligating 
into the Eco72I-linearized pEpiFOS-5 vector and transformed into the host E. coli strain Epi100. 
To make Epi100 proficient for recombineering, the Xist fosmid clone was infected with a 
replication-defective λ phage containing exo, bet and gam under the control of its native phage 
operon containing the pL promoter and temperature-sensitive repressor, cI857 (77,78). Briefly, 
Epi100 cells containing the Xist fosmid were grown to saturation in LB-Lennox broth containing 
1% maltose and 12.5µg/mL chloramphenicol, and diluted the following morning 70-fold until 
OD600 = 0.1. 3mL of culture was grown to the exponential phase OD600 = 0.6, pelleted by 
centrifugation, then washed with 1mL 10mM MgSO4, resuspended in 100µL 10mM MgSO4 
with 10µL replication-defective λ phage (λ cI857 ind1 CroTYR26amber PGLN59amber rex< >tetRA), and 
then incubated with shaking at 32°C for 1hr.  The lysogenization frequency is typically 1%; 
therefore, selection for clones containing both the fosmid and stable integration of the defective 
prophage is done by plating dilutions of clones on 2xYT agar plates containing 12.5µg/mL 
chloramphenicol and 10µg/mL tetracycline at 32°C. Clones containing the stable-integrated 
lysogen will be tetracycline resistant and do not express the prophage exo, bet and gam at 32°C, 
but can be induced to make the recombineering proteins conditionally by shifting the 
temperature of bacteria to 42°C. For production of a stock of λ phage lysate, bacterial strain 
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LE392 (K9981, Promega) containing lysogen (λ cI857 ind1 CroTYR26amber PGLN59amber rex< >tetRA) 
was induced to produce phage by shifting an exponentially growing culture in terrific broth to 
42°C for 15min, and lysing by then shifting to 39°C for 1hr containing 50µL BCP (B9673-
200ML, Millipore Sigma) (77). 
The final pCARGO-RMCE-Xist was generated by transforming 3µL of 300ng linearized 
capture vector pCARGO-RMCE-Xist-RFP into recombineering proficient WI1-2121K18 after 
42°C induction for 15min and washes to make cells electrocompetent essentially as described by 
(78). Recombineered clones were visually inspected for only white colonies, then screened for a 
5′ recombinant and 3′ recombinant junction generated by a successful gap repair event (data not 
shown), and 33 of 66 clones were positive by PCR screening. Ten clones were miniprepped and 
digested with PstI-HF or triple cut with PacI/AsiSI/AscI and 2 out of 10 clones were correct by 
restriction mapping. Correctly retrieved clones also contained the parental BAC as evidenced by 
streaking on 12.5µg/mL chloramphenicol 2xYT plates. Plasmid DNA was purified by standard 
silica-column purification and 1ng of pCARGO-RMCE-Xist was transformed into 40µL 
electrocompetent Epi300 (EC300110, Lucigen).  A representative clone was restreaked on a 
12.5µg/mL chloramphenicol 2xYT plate and was antibiotic sensitive. This clone was used to 
prepare transfection quality plasmid DNA for RMCE using the NucleoBond ® BAC 100 
purification kit (Macherey-Nagel).  
Independently, the first 2016 nucleotides of Xist (Xist-2kb) was PCR amplified and 
cloned into the MluI-HindIII sites in pCARGO-RMCE by Genewiz, Inc. Similarly, exon6-
intron-exon7 were PCR amplified from the Xist Fosmid (WI1-2121K18) and cloned into the 
AatII and XhoI sites in pCARGO-RMCE-Xist-2kb by Genewiz. The first 5588 nucleotides of 
Xist (Xist-5.5kb) was PCR amplified from the Xist Fosmid (WI1-2121K18) using (NEBNext HF 
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2x master mix, M0541S) and cloned into the ClaI sites in pCARGO-RMCE. Note that not all of 
5588 nucleotides of the endogenous Xist sequence were successfully cloned into the vector – see 
description in results section as well as Figure 2.4A and Supp Figure 2.3A. The pCARGO-Xist-
2kb, pCARGO-Xist-5.5kb, and pCARGO-Xist-2kb+6,7 plasmids were prepared for 
electroporation using the PureLink HiPure MidiPrep kit (Invitrogen). 
2.4.11 Generation of clonal ESCs inducibly expressing Xist-2kb, Xist-5.5kb, Xist-2kb+6,7, 
and full-length Xist from the Rosa26 locus 
To insert sequences carried on pCARGO into the Rosa26 locus of the RMCE cell line 
described above, the pCARGO plasmid (empty pCARGO [6.25µg] or pCARGO carrying Xist-
2kb [6.25µg] or full-length Xist [19µg]) was coprecipitated with pOG-Cre at an approximate 
ratio of 1:2.4 (pOG-Cre:pCARGO) by plasmid copy number, along with 6µg of an additional 
plasmid containing a hygromycin resistance gene (to provide transient hygromycin resistance). 
For Xist-5.5kb and Xist-2kb+6,7, the pCARGO plasmid (pCARGO-Xist-5.5kb [9.5ug] or 
pCARGO-Xist-2kb+6,7 [18.83ug]) was coprecipitated with pOG-CRE at an approximate ratio of 
1:1 by plasmid copy number. The plasmids were precipitated and resuspended in 10µL TE and 
mixed with 1x10^6 Rosa26-RMCE cells for electroporation using the Neon® Transfection 
System (Invitrogen) with a 100µL pipette tip. Electroporation conditions were 1 pulse, 40ms, 
1000V. Following electroporation, cells were plated on a 10cm plate seeded with 1.5x10^6 
gamma-irradiated multi-drug resistant DR4 MEFs (ATCC® SCRC-1045) in ESC medium 
without penicillin/streptomycin. Approximately 48hr after selection, medium was changed to 
normal ESC medium with penicillin/streptomycin. At 72hr, hygromycin was added to the 
medium at 150µg/mL. After 4d of hygromycin selection, 3µM ganciclovir was added along with 
the hygromycin. Colonies were picked when ready (approximately 4d after adding ganciclovir, 
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or 11d after electroporation) and maintained on gamma-irradiated DR4 MEFs with hygromycin 
and ganciclovir. 
Freezer stocks and genomic DNA were prepared from each colony.  Genomic DNA 
(gDNA) was prepared by incubating cells overnight at 55°C in 400µL ESC lysis buffer (100mM 
Tris-HCl, pH 8.0, 5mM EDTA, pH 8.0, 200mM NaCl, 0.2% SDS) per well of a 24-well plate 
supplemented with 80µL Proteinase K (20mg/mL; Denville Scientific) and 8µL linear 
acrylamide, followed by 1hr at 100°C. gDNA was precipitated by adding 960µL cold 100% 
ethanol, rotating 15min at 4°C, and spinning at 16.1xrcf for 5min at 4°C. The gDNA pellet was 
washed with 1mL 80% ethanol and resuspended in 100µL TE overnight at room temperature. 
Genotyping PCR reactions were performed with gDNA using Apex Taq DNA 
Polymerase (Genesee Scientific). Primer pairs (RMCE_PCR1 and RMCE_PCR2 in Supp Table 
2.3) either amplified a product in the non-recombined Rosa26 target locus (no insertion from 
pCARGO) or in the recombined locus (pCARGO inserted). 
To generate RMCE cells inducibly expressing the inserted pCARGO sequences, an rtTA 
gene was inserted using piggyBac-mediated transgenesis. Briefly, 4x10^5 RMCE cells were 
seeded in a single well of a 6-well plate, and transfected 24hr later with 0.5 µg rtTA-cargo and 1 
µg of pUC19-piggyBAC transposase (79) using Lipofectamine 3000 (Invitrogen) according to 
manufacturer instructions. Cells were selected for 7-9 days with G418 (200 µg/mL) beginning 
24hr after transfection. Inducible pCARGO sequence expression was verified by RT-qPCR and 
RNA FISH. 
2.4.12 RNA sequencing and analysis 
Replicates for RNA-seq were as follows: for Rosa26-RMCE empty-cargo and Xist-2kb 
cells, fractionated RNA was prepared from 2 independent clones, one independently induced 
with doxycycline twice and one induced once (3 replicates each); for Rosa26-RMCE Xist-5.5kb 
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and Xist-2kb+6,7 cells, fractionated RNA was prepared from 2 independent clones each induced 
once (2 replicates each), and for Xist-full length cells, fractionated RNA was prepared from 1 
clone independently induced twice (2 replicates); for pSM33 cells, fractionated RNA was 
prepared from 2 independent platings each (different days) for both 0 and 24 hours after 
doxycycline addition, and 1 independent plating each for 3 and 5 hours after doxycycline 
addition. 
RNA-seq libraries were prepared using the RNA HyperPrep Kit with RiboErase (Kapa 
Biosciences) and sequenced on an Illumina NextSeq 500 machine using a 75-cycle high output 
NextSeq kit (Illumina). Sequencing reads were aligned to mm9 genomic sequence using Star 
(version 2.5.4b; (80)) with default parameters. All mm9 genome annotations were obtained from 
the UCSC genome browser (81). Variant sequence data were obtained from the Sanger Institute 
(http://www.sanger.ac.uk/resources/mouse/genomes/). Only reads that had a mapping quality 
greater than or equal to 30 were used. CAST/EiJ pseudogenome creation and allele-specific read 
retention was performed as in (82,83). Reads were assigned to genes using FeatureCounts (84). 
Differential expression analysis (comparing allelic cytosolic counts between empty pCARGO 
and Xist transgene line or between 0hr induced pSM33 cells and 24h induced pSM33 cells) was 
done using DESeq2 (85). MA plots were generated using the plotMA function in DESeq2 with 
default settings after shrinking log2fold changes (lfcShrink function in DESeq2). To quantify 
nuclear fraction of transcripts, upper quartile-normalized nuclear and cytosolic counts for each 
gene were added together and the normalized nuclear count values were divided by the total. All 
genome-related plots were generated using R (version 3.4.4; (86)). 
2.4.13 Immunoprecipitation 
IP experiments were performed using a modified version of a protocol from (87). ESCs 
were trypsinized and washed once with PBS before being fixed in 0.3% methanol-free 
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formaldehyde (Pierce) for 30min with rotation at 4°C. Formaldehyde was quenched with 125mM 
glycine for 5min at room temperature. ESCs were then washed three times with PBS, snap 
frozen in liquid nitrogen, and stored at -80°C.  
24hr prior to IP, 5µL of SPEN (Novus; NBP1-82952) or RBM15 (Proteintech; 10587-1-
AP) antibodies were preconjugated with 25µL of ProteinA/G agarose beads (Santa Cruz) for 
each IP performed in a solution of PBS and 0.5% BSA. On the day of the IP, beads were washed 
once with PBS and 0.5% BSA and once with fRIP buffer (25mM Tris-HCl pH 7.5, 5mM EDTA, 
0.5% Igepal CA-630, 150mM KCl) before being added to sonicated cell lysates. 
Prior to sonication,10x10^6 crosslinked ESCs were resuspended in 0.5mL RIPA buffer 
(50mM Tris-HCl pH 8, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, 5mM EDTA, 
150mM KCl) + 0.5mM DTT with 1:100 protease inhibitor cocktail (Sigma) and 2.5µL RNAsin 
and sonicated using a Vibracell VX130 (Sonics) with two cycles of 30% intensity for 30sec with 
1min of rest on ice between cycles, followed by centrifugation at 4°C for 15min at 16100xrcf.  
Sonicated ESC lysates were diluted with 0.5mL fRIP buffer plus 0.5mM DTT, 1:100 
protease inhibitors, and 2.5µL RNAsin. 5x10^6 ESC equivalents were then incubated overnight 
at 4°C on a rotating platform with washed, antibody-conjugated beads. The following day, beads 
were washed once with ice cold fRIP buffer and then transferred to a clean tube. Beads were then 
washed 3 times in ice cold ChIP buffer (50mM Tris-HCl pH 7.5, 140mM NaCl, 1mM EDTA, 
1mM EGTA, 1% Triton X-100, 0.1% sodium deoxycholate, 0.1% SDS), once in ice cold high 
salt buffer (ChIP buffer, but with 500mM NaCl) and once in ice cold LiCl wash buffer (20mM 
Tris pH 8.0, 1mM EDTA, 250mM LiCl, 0.5% NP-40, 0.5% Na-deoxycholate), changing tubes 
again at the final wash. Each wash (except the first fRIP wash) was performed for 5min with 
rotation at 4°C. After the final wash, beads were resuspended in 1X reverse crosslinking buffer 
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(1x PBS, 2% N-lauroyl sarcosine, 10mM EDTA) supplemented with 5mM DTT, 20µL 
proteinase K, and 1µL RNAsin and incubated 1hr at 42°C, 1hr at 55°C, and 30min at 65°C. 1mL 
of Trizol was used to extract RNA, and the aqueous phase was supplemented with 1 volume of 
ethanol and purified using a Zymo-spin IC column, including the on-column DNAse digestion, 
per the manufacturer's instruction. RNA was eluted in 15µL ddH20 and 2µL from each IP 
condition was reverse transcribed using the MultiScribe High Capacity Kit (Applied Biosystems) 
with random primers. qPCR was performed using iTaq Universal SYBR Green (Bio-Rad) and 
custom primers (Supp Table 2.3). 
2.4.14 SPEN deletion 
To delete SPEN in E14 ESCs, 4 different sgRNAs flanking (2 on each side) an 
approximately 40kb genomic region including 3 of the 4 annotated RNA recognition motifs in 
SPEN were cloned into pX330-U6-Chimeric_BB-CBh-hSpCas9 (a gift from F. Zhang; Addgene 
plasmid #42230; (88); see diagram in Supp Figure 2.7A and oligo sequences used for cloning in 
Supp Table 2.3). Flanking sgRNAs were designed using CRISPETa (89). A pool of all 4 
sgRNAs each inserted into pX330 were prepared using the PureLink HiPure MidiPrep kit 
(Invitrogen). Transfections were performed using Lipofectamine 3000 (ThermoFisher) according 
to the manufacturer’s protocol. Briefly, 5x10^5 E14 cells were plated to one well of a 6-well 
plate the day before transfecting. 800ng of the pX330 pool and 200ng of a plasmid containing a 
puromycin resistance gene were mixed with 2µL P3000 reagent and Opti-MEM to 125µL. This 
mixture was added to 7.5µL Lipofectamine 3000 reagent diluted in 117.5µL Opti-MEM and 
incubated for 5min at room temperature before adding the entire mixture to the cells in fresh 
ESC medium. After 24hr, medium was changed and puromycin was added to 2µg/mL to enrich 
for cells which received the plasmids. Approximately 66hr after transfection, the cells were 
plated at low density (500-6000 cells per plate) on 10cm plates seeded with gamma-irradiated 
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MEFs at 1.5x10^6 cells per plate. Cells were grown for 5-7d (without puromycin) until colonies 
were ready to be picked. Freezer stocks and gDNA were prepared from the colonies as described 
for Rosa26-RMCE clones. 
Genotyping PCR reactions were performed with gDNA using Apex Taq DNA 
Polymerase (Genesee Scientific). A pair of primers which flank the deletion were used to screen 
for deletion positive clones (PCR1 in Supp Figure 2.7A). Two primer pairs, one pair flanking 
each set of sgRNA cut sites, were used to screen deletion positive clones for homozygous 
deletion clones (PCR2 and PCR3 in Supp Figure 2.7A). Primer sequences are listed in Supp 
Table 2.3. Two homozygous deletion clones were expanded and used to generate Xist-2kb 
TETRIS lines following RT-qPCR confirmation of SPEN deletion. 
2.4.15 RBM15/RBM15B/EZH2 knockdown 
Knockdowns of RBM15/RBM15B/EZH2 were generated using two piggyBac-based 
vectors, one that expresses doxycycline-inducible Cas9 and another used to express sgRNAs 
targeting exons and the reverse-tetracycline-Transactivator rtTA, modified from (79). A 
manuscript describing our rationale and construction of these piggyBac-based vectors is in 
preparation (Schertzer et al.). To create the doxycycline-inducible Cas9 used to cut the DNA of 
genes of interest, a parent vector was created in which a bGH-polyA signal and an EF1 
promoter driving expression of a hygromycin resistance gene was ligated into the cumate-
inducible piggyBac transposon vector from System Biosciences after its digestion with HpaI and 
SpeI, which cut just downstream of each chicken -globin insulator sequence and removed all 
other internal components of the original vector. The TRE promoter from pTRE-Tight 
(Clontech) was then cloned upstream of the bGH-polyA site, and Cas9 from pX330 (88) was 
then cloned behind the TRE promoter by digestion with AgeI and SalI (NEB) followed by 
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Gibson Assembly (NEB), to generate the piggyBac cargo vector capable of inducibly expressing 
Cas9, upon addition of doxycycline. In parallel, individual sgRNAs targeting exons of interest 
were designed using Desktop Genetics. These sgRNAs were each cloned into BsmbI sites in a 
U6-sgRNA expression cassette that was inserted upstream of the rtTA3-IRES-Neo cassette in the 
rtTA-piggyBac-Cargo vector described in (79). Four sgRNAs per gene of interest were cloned in 
this manner. For each gene of interest, bacterial cultures expressing each of the four sgRNAs 
were pooled and grown overnight prior to extraction with PureLink HiPure MidiPrep kit 
(Invitrogen) of the pooled sgRNA-rtTA-expressing plasmids. Sequences of oligos used to create 
sgRNAs are listed in Supp Table 2.3. An sgRNA-rtTA-expressing plasmid with an sgRNA insert 
lacking a targeting sequence was used as a negative control in Figure 2.5. 
To generate TETRIS lines with RBM15/RBM15B/EZH2 knockdown, transfections were 
performed using Lipofectamine 3000 as described above. A total of 2.5µg of plasmid DNA was 
transfected per well of a 6-well plate at an 8:2:2:1 ratio of sgRNA-rtTA pool:piggyBac-
Cas9:TETRIS Xist-2kb:pUC19-piggyBAC transposase. Cells were selected with 2µg/mL 
puromycin, 200µg/mL G418, and 150µg/mL hygromycin for 10d, starting 24hr after 
transfection. To induce Cas9 expression and protein knockdown before performing TETRIS 
assays, cells were treated with 1µg/mL doxycycline for 4d. Following this, cells from each 
TETRIS line were split to 2 wells of a 6-well plate, one with 1µg/mL doxycycline and one 
without (for protein lysates for western blot) and to 4 wells of a 24-well plate, 2 with 1µg/mL 
doxycycline and 2 without (for lysis for luciferase assay). 
2.4.16 Western blots 
For western blot, cells were washed with 1x PBS and lysed by scraping and rotating 
15min at 4°C in RIPA buffer (10mM Tris-HCl pH 7.5, 1mM EDTA, 0.5mM EGTA, 1% NP-40, 
0.1% sodium deoxycholate, 0.1% SDS, 140mM NaCl) supplemented with 1mM PMSF and 
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1:100 protease inhibitor cocktail (Sigma). Lysates were sonicated on ice with a Vibracell VX130 
(Sonics) for 2 cycles of 10sec at 30% output and cleared by centrifuging for 15min at 16100xrcf 
at 4°C before quantifying proteins using the DC protein assay (Bio-Rad). Equal amounts of 
protein were run at 150-200V on 12% polyacrylamide gels with 5% stacking gels and transferred 
to PVDF membranes at 20V overnight. Membranes were blocked with 5% blotting-grade 
blocker (Bio-Rad) in TBST for 1hr at room temperature and divided to probe for a protein of 
interest (EZH2, RBM15, RBM15B, or luciferase) and a loading control (TBP). Primary 
incubations were done for 1.5hr at room temperature. Membranes were washed 3 times for 6min 
each with TBST at room temperature and incubated with the appropriate secondary antibody for 
40min at room temperature, 1hr at 4°C, and 20min at room temperature. Membranes were 
washed 3 times with TBST for 6min each and once with TBS for 5min at room temperature 
before developing for 5min at room temperature with Clarity Western ECL Substrate (Bio-Rad; 
EZH2 antibody) or SuperSignal West Femto Maximum Sensitivity Substrate (Thermo Scientific; 
all other antibodies) and imaging on a ChemiDoc MP Imaging System (Bio-Rad). Antibodies 
used: TBP (Abcam; ab818; 1:2000 dilution), EZH2 (Cell Signaling Technology; CS-5246; 
1:1000 dilution), RBM15 (Proteintech; 10587-1-AP; 1:1000 dilution), RBM15B (Proteintech; 
22249-1-AP; 1:1000 dilution), luciferase (Promega; G7451; 1:1000 dilution), donkey anti-mouse 
IgG-HRP secondary (Santa Cruz; sc-2314; 1:2500), donkey anti-rabbit IgG-HRP secondary 
(Santa Cruz; sc-2313; 1:2500), donkey anti-goat IgG-HRP secondary (Santa Cruz; sc-2020; 
1:5000). 
2.4.17 CLIP analysis 
To analyze crosslinking immunoprecipitation (CLIP) data from (43,72), sequencing data 
CLIP with SPEN, HNRNPK, SAFA, LBR, PTBP1, and DKC were downloaded from GEO 
accession numbers GSE86250 (SPEN, LBR, PTBP1, and input) and GSE87233 (HNRNPK, 
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SAFA, DKC) and aligned to the mouse genome. Aligned reads were assigned to genes using 
featureCounts (84), and counts per gene for each dataset were normalized to total aligned reads 
for the dataset. Supp Table 2.4 shows gene ID, chromosome, and normalized counts for input, 
SPEN, HNRNPK, SAFA, LBR, PTBP1, and DKC. 
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Figure 2.1. Xist-2kb represses luciferase at the post-transcriptional level.(A) Schematic of 
TETRIS Xist-2kb expression construct. ITR, inverted terminal repeat recognized by piggyBac 
transposase. HS4, chicken globin insulator sequence. TRE, tetracycline responsive element (the 
doxycycline inducible promoter). Xist-2kb, nucleotides 1 to 2016 of mouse Xist. Luc, firefly 
luciferase (pGL4.10). PGK and EF1, constitutive promoters. PuroR, gene encoding resistance 
to puromycin.  Black ovals, location of polyA sites. (B) Representative assay showing Xist-2kb 
and Hottip effects on luciferase protein activity (see also (49)). Error bars, bootstrap 95% 
confidence interval of the mean derived from technical duplicate measurements from each of 
three separate cell platings (biological triplicates). (C) Luciferase mRNA increases upon 
induction of Xist-2kb and Hottip. Error bars, bootstrap 95% confidence intervals of the mean 
derived from duplicate qPCR measurements from each of three separate cell platings. (D) 
Luciferase mRNA increase in Xist-2kb ESCs is specific to the sense strand of the luciferase gene 
and not due to readthrough transcription from Xist-2kb. Values from sense- and antisense-
specific RT reactions are normalized to Gapdh signal from a random primer RT and set relative 
to no dox values for each strand-specific primer. Error bars, bootstrap 95% confidence intervals 
around the mean as calculated in (C). Sense (S) and Antisense (AS) relative primer locations are 
shown in (A). See also Supp Figure 2.1 and Supp Table 2.3. 
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Figure 2.2. Xist-2kb sequesters mRNA on chromatin.(A) Xist-2kb sequesters mRNA from the 
luciferase (Luc) and puromycin resistance (PuroR) genes on chromatin. Gapdh and Malat1/Xist-
2kb are controls to monitor quality of cytoplasmic (Cyt), nucleoplasmic (Nuc), and chromatin 
(Chr) fractionations. Error bars represent standard deviation propagated across two qPCR 
technical replicates of duplicate RNA fractionations. (B) Sequestration requires continued 
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expression of Xist-2kb. TETRIS-Xist-2kb cells were grown in the presence of doxycycline for 
two days, prior to splitting at Day 2 and a two-day release from doxycycline. ESCs were then 
split into two cultures at Day 4 and doxycycline was re-added to one culture and not the other. 
Error bars, bootstrap 95% confidence interval of the mean derived from technical duplicate 
measurements taken from each of three separate platings. (C) Stability of luciferase and PuroR 
mRNA in TETRIS Xist-2kb and Hottip ESCs with and without dox-induced expression. Cells 
were either induced or not induced for ~16hr, then treated with 5µg/mL actinomycin D. Each 
point shows the average of technical duplicate qPCR measurements of one of three biological 
replicate platings normalized to Gapdh and set relative to 0hr on a log2 scale. Linear models 
were fit to the data, plotted with 95% bootstrap confidence intervals, and used to calculate half-
lives (t1/2). To compare regression lines between uninduced (– dox) and induced (+ dox), a single 
linear regression model was built including an interaction term between time and induction. 
***p<0.001; *p<0.05, hypothesis test using linear regression model with interaction effect. (D) 
RT-qPCR analysis of Gapdh RNA and Malat1 lncRNA to assess loading and fractionation 
quality of RNA prepared from unfractionated parental E14 ESCs (E14 total), unfractionated 
TETRIS Xist-2kb ESCs (Total), and TETRIS Xist-2kb ESCs fractionated into nuclear (Nuc) and 
cytoplasmic (Cyt) fractions. TETRIS Xist-2kb ESCs were incubated for 48hr in the absence (- 
dox) or presence (+ dox) of 1µg/mL doxycycline prior to harvesting. For each primer pair, RNA 
abundance values are normalized relative to the average “Total -dox” value, which was 
arbitrarily set to 1. Each dot represents the RNA abundance from a biological replicate cell 
plating (n=1 for E14 total, n=3 for all others), each calculated as the average of technical 
triplicate qPCR measurements. Error bars represent standard deviation of biological replicate 
values. (E, F) Tiled RT-qPCR analysis of luciferase (E) and PuroR (F) mRNAs from the same 
RNA samples used in (D). Measurements and error bars as in (D). Lack of signal in the “E14 
total” sample demonstrates specificity of the primer pairs for luciferase and PuroR mRNA. 
Primer pair locations are indicated under each plot. Protein-coding sequence of each mRNA is 
depicted by the thicker lines. (G) Stellaris single-molecule FISH was performed to visualize Xist 
RNA (red) and luciferase mRNA (green) in Xist-2kb cells with and without 48hr treatment with 




Figure 2.3. Sequestration depends on GC-rich sequence elements in Repeat-A and can be 
induced by Xist-like, synthetic lncRNAs.(A) Schematic of Xist-2kb showing the location of 
Repeat-A, Repeat-F, stably structured elements (SS; (38)), and mutants that reduce repressive 
activity in TETRIS (49). (B) mRNA sequestration requires the GC-rich portions of Repeat-A and 
three stably structured elements and their intervening sequence located downstream. 
Measurements and error bars as in Figure 2.2A. (C) Xist RNA is induced to a lesser extent in 
deletion mutants. Error bars, bootstrap 95% confidence intervals of the Gapdh-normalized mean 
derived from duplicate qPCR measurements from each of four separate cell platings. (D) Xist 
RNA is less chromatin-associated in Xist mutant TETRIS lines. Measurements and error bars as 
in Figure 2.2A, but showing only results from doxycycline-induced (+) cells. Wild-type Xist-2kb 
localization data from Figure 2.2A are included again for comparison. (E) Representative 
luciferase assay data from TETRIS-Empty, -Xist-2kb, and the six synthetic lncRNAs from (49). 
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Measurements and error bars as in Figure 2.1B. Each synthetic lncRNA is 1,650 nucleotides 
long. Similarity of each synthetic lncRNA to Xist-2kb measured by Pearson similarity at kmer 
length k=6 as in (49) is listed in parenthesis. (F) Subcellular localization of Luciferase mRNA, 
Malat1 lncRNA, and Gapdh mRNA upon expression of TETRIS-Empty, -Xist-2kb, and the six 
synthetic lncRNAs from (49). Error bars represent standard deviation propagated across two 
technical replicates of qPCR from a single fractionation experiment. Data shown are 
representative of three independent fractionation experiments. See also Supp Table 2.3. 
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Figure 2.4. Xist hypomorphs sequester nearby mRNA on chromatin as single-copy 
insertions.(A) Schematic of endogenous Xist locus with Xist insertions. Repeats A-F and exon 
locations are shown. (B) Stellaris single-molecule FISH for Xist RNA (red) in cells expressing 
Xist-2kb, Xist-5.5kb, Xist-2kb+6,7, or full-length Xist inserted at Rosa26 with and without 
doxycycline. DAPI-stained nuclei are blue. Scale bar=10µm. (C) Xist expression in each ESC 
line. Reads per kilobase per million (RPKM) values were calculated using reads aligned to the 
endogenous Xist locus divided by length of inserted transcript in kb divided by total aligned 
reads in millions for each dataset. (D) Venn diagram showing overlap between significantly 
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repressed genes in Xist-5.5kb, Xist-2kb+6,7, and full-length Xist cells. (E) Nuclear ratio of reads 
mapping to HygroR. ***p<0.0001, Tukey HSD post-hoc analysis of significant differences by 
ANOVA. (F) Nuclear ratio of allele-specific reads mapping to Setd5. Note the difference in y-
axis compared to (E). ***p<0.0001; *p<0.01, Tukey HSD post-hoc analysis of significant 
differences by ANOVA. (G) Stellaris single-molecule FISH was performed to visualize Xist-2kb 
RNA (red) and HygroR mRNA (green) in cells with Xist-2kb inserted at Rosa26 with and 
without 48hr treatment with doxycycline. DAPI-stained nuclei are blue. Scale bar=10µm. (H) 
Normalized nuclear counts relative to empty-cargo ESCs for hygromycin resistance (HygroR) 
mRNA. (I) Allele-specific normalized nuclear counts relative to empty-cargo ESCs for Setd5 
mRNA on the B6 allele. (J) Hygromycin resistance (HygroR) mRNA levels measured by RT-
qPCR from total cellular RNA and normalized to Gapdh. Cells expressing empty-cargo or Xist 
transgenes were induced (1 µg/mL doxycycline) for 2 days prior to RNA extraction. Expression 
in each line is set relative to that in empty-cargo ESCs. Error bars, bootstrap 95% confidence 
intervals of the mean derived from duplicate qPCR measurements from each of two (Xist-full 
length), three (empty-cargo and Xist-2kb), or four (Xist-5.5kb and Xist-2kb+6,7) separate cell 
platings. (K) Similar to (J) but for Setd5 mRNA. See also Supp Figure 2.2, Supp Figure 2.3, 
Supp Figure 2.4, Supp Figure 2.5, Supp Table 2.1, Supp Table 2.2, and Supp Table 2.3. 
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Figure 2.5. SPEN and RBM15 associate with Xist-2kb but are not required for repression 
in TETRIS.(A) Xist-2kb diagram showing the location of Repeat A and three stably structured 
elements (ss2-4) as well as the qPCR primers used in RNA IP. (B) Immunoprecipitation verifies 
Repeat-A-dependent association of SPEN and RBM15 in TETRIS-Xist2kb ESCs. IPs were 
performed in the parent cell line, E14, which does not express Xist at appreciable levels but does 
express the antisense lncRNA Tsix, in TETRIS-Xist-2kb ESCs with and without a 48hr treatment 
of doxycycline, and in Xist-∆rA234 ESCs after a 48hr treatment with doxycycline. RT-qPCR 
signal from RNA prepared from each IP was plotted relative to input RNA from Xist-2kb +dox 
cells. Error bars, bootstrap 95% confidence interval of the mean derived from triplicate qPCR 
measurements from a representative IP experiment. In all, the SPEN IP was conducted four times 
and the RBM15 IP was conducted twice. (C) Spen mRNA is absent in TETRIS Xist-2kb lines 
made in two independent lines of homozygous SPEN deletion cells. Error bars, bootstrap 95% 
confidence intervals of the mean derived from duplicate qPCR measurements from each of two 
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separate cell platings. (D) Luciferase assay showing that SPEN deletion has no effect on 
repression of luciferase protein activity by expression of Xist-2kb in TETRIS. Error bars, 
bootstrap 95% confidence interval of the mean derived from technical duplicate measurements 
from each of four separate cell platings. (E) Western blots confirm knockdown of RBM15, 
RBM15B, and EZH2 in TETRIS Xist-2kb lines with and without doxycycline treatment. ‘rtTA’: 
non-targeting gRNA sequence (negative control); ‘Both’: simultaneous targeting of both RBM15 
and RBM15B. (F) Luciferase assay showing that none of the knockdowns influence repression 
of luciferase protein activity by expression of Xist-2kb in TETRIS. Error bars, bootstrap 95% 
confidence interval of the mean derived from technical duplicate measurements from each of 
three separate cell platings. See also Supp Figure 2.7 and Supp Table 2.3.
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Supp Figure 2.1. Further characterization of Xist-2kb expression in TETRIS Xist-2kb cells. 
Related to Figure 2.1 and Figure 2.2. (A) Schematic of Xist-2kb showing the location of 
Repeat-A, Repeat-F, stably structured elements (SS; (38)), and deletions in mutants that reduce 
repressive activity in TETRIS (49). Sequences of Repeat-A monomers are below; breaks mark 
start of each sub-deletion in the rA (no GC) mutant. (B) Western blot confirms reduction in 
luciferase protein after 48hr of doxycycline-induced expression of Xist-2kb in TETRIS cells. 
TBP is included as a loading control. (C) Induction of Xist-2kb sensitizes TETRIS Xist-2kb cells 
to puromycin. Cells were grown for 2 days with or without doxycycline (1µg/mL) before equal 
numbers of cells were plated in medium containing puromycin (2µg/mL) with or without 
doxycycline. Cells were trypsinized and counted after 24hr and 48hr of puromycin treatment. 
Cell survival is shown relative to cells grown without doxycycline. Error bars, bootstrap 95% 
confidence interval of the mean derived from counting two wells for each condition (technical 
duplicates) from each of two separate cell platings (biological duplicates).
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Supp Figure 2.2. Rosa26-RMCE system for inducible expression of inserted transgenes. 
Related to Figure 2.4. (A) Generation of targeting locus at Rosa26. PGK, constitutive promoter. 
loxP66 and loxP2272, Cre recombinase recognition sequences. PuroΔTK, gene encoding 
puromycin resistance (for positive selection) and truncated thymidine kinase (for negative 
selection with ganciclovir). (B) Southern blot confirming successful targeting of the B6 allele, 
using a probe that detects a region 3′ of the 3′ Rosa26 homology arm. “Clone #1” was expanded 
and used for the RMCE experiments in this work. (C) RMCE insertion of pCARGO vector 
Cargo into targeting locus at Rosa26. loxP71, Cre recombinase recognition sequence for 
recombination with loxP66. TRE, tetracycline responsive element (the doxycycline inducible 
promoter). Hygro, gene encoding resistance to hygromycin. FRT, Flp recombinase target. (D) 
Targeted locus after RMCE insertion of Cargo. loxP66/71*, recombined site no longer usable by 
Cre recombinase, preventing removal of cassette.
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Supp Figure 2.3. Xist transgenes are expressed from the Rosa26 locus. Related to Figure 
2.4. (A) The Xist-5.5kb transgene aligned to the Repeat-B portion of endogenous Xist (254bp 
total) shows a deletion of 136bp. (B) Wiggle tracks showing nuclear Xist read density in one 
representative replicate of each Xist transgene line. Reads are aligned to the endogenous Xist 
locus, which is not expressed in these cells (as seen in the empty-cargo line). (C) Nuclear ratio of 
reads mapping to Xist in each Xist transgene expressing line. See also Supp Table 2.1, Supp 




Supp Figure 2.4. Location and levels of genes silenced by Xist transgenes. Related to Figure 
2.4. (A) MA plot showing differential expression between empty-cargo cells and full-length Xist 
cells on the B6 allele of chromosome 6. Log fold change was plotted against the mean of 
normalized allelic cytosolic counts. Each dot is an expressed gene, and red dots show 
significantly changing genes as determined by DESeq2 analysis (adjusted p value < 0.05). Red 
triangle indicates gene below the lower y-axis limit. Locations of all expressed genes along 
chromosome 6 are shown above the plot. Genes which increase, decrease, or do not change in 
full-length Xist cells are marked by green, red, and grey bars, respectively. The location of Xist 
on the B6 allele is indicated. (B) Similar to (A) but for the Cast allele. For comparison, the 
transgene location from the B6 allele is indicated. (C-H) Similar to (A, B) but for expression of 
Xist-5.5kb (C, D), Xist-2kb+6,7 (E, F), and Xist-2kb (G, H). See also Supp Table 2.1, Supp Table 
2.2, and Supp Table 2.3.
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Supp Figure 2.5. Xist transgenes silence genes across chromosome 6 at the transcriptional 
level. Related to Figure 2.4. (A-C) Average allele-specific normalized nuclear counts relative to 
empty-cargo ESCs for the 205 genes significantly repressed by full-length Xist (A), the 65 genes 
significantly repressed by Xist-2kb+6,7 (B), or the 76 genes significantly repressed by Xist-5.5kb 
(C). (D) Average nuclear ratio of allele-specific reads for the 205 genes significantly repressed 
by full-length Xist. See also Supp Table 2.1, Supp Table 2.2, and Supp Table 2.3.
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Supp Figure 2.6. Lack of evidence for stable mRNA sequestration at the onset of X-
inactivation. (A) MA plot showing differential expression of genes on the X chromosome in 
pSM33 ESCs before and 24 hours after addition of doxycycline. Log fold change was plotted 
against the mean of normalized cytosolic counts. Each dot is an expressed gene, and red dots 
show significantly changing genes as determined by DESeq2 analysis (adjusted p value < 0.05). 
Locations of all expressed genes along the X chromosome are shown above the plot. Genes 
which increase, decrease, or do not change are marked by green, red, and grey bars, respectively. 
Note: the single upregulated gene is Xist. The location of Xist is indicated. (B) Average nuclear 
ratio for genes significantly silenced by Xist (red dots below 0 in (A)) at 0, 3, 5, and 24 hours 
post addition of doxycycline in pSM33 ESCs. (C) Average normalized cytosolic counts of genes 
significantly silenced by Xist at 3, 5, and 24 hours in pSM33 ESCs, set relative to the 0-hour time 




Supp Figure 2.7. SPEN, RBM15, RBM15B, and EZH2 knockdown strategy. Related to 
Figure 2.5. (A) Gene diagram showing the location of Spen exons, annotated functional domains 
(above the gene), sgRNA target locations (below the gene), and genotyping PCR products 
(below the sgRNA locations). (B) SPEN deletion genotyping PCR gels showing the presence of 
deletion-specific bands and absence of wild-type-specific bands in gDNA from two homozygous 
deletion clones. E14 gDNA (‘WT’) is included as a wild-type control. (C-E) Gene diagrams 
showing the location of exons and sgRNA target locations for Rbm15 (C), Rbm15b (D), and 
Ezh2 (E). See also Supp Table 2.3.
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Supp Table 2.1. Allele-specific raw and normalized nuclear and cytosolic counts for all 
genes detected as differentially expressed in any of the Xist transgene lines. Sheet 1 
(‘all_changers’) contains raw allele-specific read counts for each replicate of each cell line for 
every gene detected as significantly differentially expressed in any of the Xist transgene lines 
compared to the empty line. Sheet 2 (‘all_changers_norm’) contains the upper quartile 
normalized counts for each gene and line as in Sheet 1. Sheet 3 (‘deseq2_results’) contains the 
log 2 fold changes (‘L2FC’) and adjusted p-values (‘PAdj’) for each DESeq2 comparison for 
each gene detected as significantly differentially expressed in any of the Xist transgene lines. 
Table attached.  
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Supp Table 2.2. Raw and normalized nuclear and cytosolic counts for the hygromycin 




Empty_1_cyt 8449 7.064381 
Empty_1_nuc 1310 4.15873 
Empty_2_cyt 7224 7.801296 
Empty_2_nuc 900 3.585657 
Empty_3_cyt 7886 10.41744 
Empty_3_nuc 1379 4.178788 
Xist-2kb_1_cyt 664 0.563667 
Xist-2kb_1_nuc 1752 4.773842 
Xist-2kb_2_cyt 579 0.866766 
Xist-2kb_2_nuc 2691 10.51172 
Xist-2kb_3_cyt 560 0.584551 
Xist-2kb_3_nuc 1601 5.597902 
Xist-5.5kb_1_cyt 567 0.875 
Xist-5.5kb_1_nuc 1608 8.162437 
Xist-5.5kb_2_cyt 598 0.958333 
Xist-5.5kb_2_nuc 1920 10.72626 
Xist-2kb+6,7_1_cyt 125 0.190549 
Xist-2kb+6,7_1_nuc 151 0.811828 
Xist-2kb+6,7_2_cyt 153 0.221739 
Xist-2kb+6,7_2_nuc 162 0.905028 
Xist-full_1_cyt 201 0.216362 
Xist-full_1_nuc 37 0.131673 
Xist-full_2_cyt 234 0.205443 
Xist-full_2_nuc 24 0.09375 
  
65 
Supp Table 2.3. Sequence and description of all oligonucleotides used. Oligonucleotide 
sequences are listed, along with usage, relevant figure and/or methods section, and source 
references. 
Table attached.  
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Supp Table 2.4. CLIP analysis for 6 proteins including SPEN. Sequencing data for 
crosslinking immunoprecipitation (CLIP) with SPEN, HNRNPK, SAFA, LBR, PTBP1, and 
DKC were downloaded from GEO accession numbers GSE86250 (SPEN, LBR, PTBP1, and 
input) and GSE87233 (HNRNPK, SAFA, DKC) and aligned to the mouse genome. Aligned 
reads were assigned to genes using featureCounts (http://subread.sourceforge.net/), and counts 
per gene for each dataset were normalized to total aligned reads for the dataset. Table shows 




CHAPTER 3: EXAMINING THE MECHANISM OF XIST-INDUCED 
SEQUESTRATION
3.1 INTRODUCTION 
We have identified and characterized the previously unobserved phenomenon of 
lncRNA-induced sequestration of target RNA transcripts. Major questions remain about the 
mechanism by which lncRNAs can sequester transcripts, as well as the biological role the 
phenomenon may play in regulating transcription, RNA processing, and RNA export. As 
discussed in Chapter 2, one intriguing aspect of Xist-induced sequestration is the presence of 
many splicing and export factors in the list of proteins which associate with Xist, as well as those 
which have been shown to be necessary for its silencing function (13,24). Recent studies have 
also shown that splicing of lncRNAs can regulate transcription of the lncRNAs themselves and 
of enhancer lncRNAs and associated transcripts (90,91), and that splicing of mRNA promotes 
more rapid and efficient nuclear export (92). These observations led us to predict that one aspect 
of Xist-induced sequestration may be interference in processing of RNA transcripts of target 
genes. More specifically, we hypothesized that Xist may be interacting, likely through Repeat-A,  
with splicing factors at its target loci in ways that interfere with splicing and export of target 
gene transcripts (44-47). To test this hypothesis, we took advantage of the RNA-seq data 
performed on cell fractions following induction of endogenous Xist and Xist transgenes described 
in Chapter 2. A specific increase in nuclear localization of unspliced transcripts following Xist or 
Xist transgene induction would suggest preferential sequestration of those transcripts as a result 
of blocks to splicing and/or export.  
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3.2 RESULTS 
To examine whether there was a difference in cellular localization between spliced and 
unspliced transcripts in mouse F1-hybrid ESCs expressing Xist transgenes from the Rosa26 
locus, we took advantage of the distinct SNPs between the parental lines. Sequencing reads 
which overlapped SNPs in genes were filtered by whether the informative SNP was in an intron 
or exon. While reads overlapping exonic SNPs could derive from a spliced or unspliced 
transcript, those which overlap intronic SNPs should derive exclusively from unspliced 
transcripts. For the 205 genes on chr6 which were significantly silenced by expression of full-
length Xist (described in Chapter 2.2.3), we then compared the normalized counts of nuclear and 
cytosolic reads for exonic and intronic SNP-overlapping reads in ESCs expressing each Xist 
transgene by setting the counts relative to empty-cargo ESCs (Figure 3.1). We observed similar 
patterns between reads overlapping exonic (Figure 3.1A, B) and intronic (Figure 3.1C, D) SNPs. 
If unspliced transcripts were being preferentially sequestered, we would have seen a difference 
between cytosolic and nuclear reads which overlap intronic SNPs (Figure 3.1C, D). 
We performed a similar analysis for the genes significantly silenced by induced 
expression of full-length Xist from the endogenous locus in pSM33 ESCs for 24h (described in 
Chapter 2.2.4). In this case, we directly estimated expression levels of spliced and unspliced 
transcripts in cytosolic and nuclear fractions and set the normalized counts relative to uninduced 
ESCs (Figure 3.2). Preferential sequestration of unspliced transcripts at any time point would 
lead to a higher level of normalized nuclear counts for unspliced reads. Again, we concluded that 
this was not the case because of the similar patterns between cytosolic and nuclear spliced reads 
(Figure 3.2A, B) and unspliced reads (Figure 3.2C, D). 
To further examine the amino acid content of disordered domains in human and mouse 
RNA binding proteins, we extracted the amino acid sequences from the Pfam database (93). 
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Sequences for all mouse proteins, all human proteins, and all disordered domains in mouse and 
human were extracted as fasta files and stored on the longleaf computing cluster for future use 
(see Methods in Chapter 3.4.3). 
3.3 DISCUSSION 
From the additional analyses performed on the RNA sequencing data described in 
Chapter 2, we do not see evidence of preferential sequestration of unspliced transcripts. It is 
possible that splicing of target transcripts is being inhibited by Xist expression, leading to 
sequestration, and that we have not observed it at the time points we have examined. However, it 
is also quite possible that the mechanism of Xist-induced sequestration is unrelated to splicing 
inhibition. We are continuing to probe potential mechanisms of sequestration, specifically 
focusing on identifying Xist cofactors which are required for the phenomenon and on 
understanding the role disordered domains may be playing by potentially contributing to 
formation of an Xist-seeded protein/RNA aggregate. 
3.4 METHODS 
3.4.1 Parsing reads for exonic or intronic SNPs 
RNA sequencing, alignment, and assignment of SNP-overlapping reads from ESCs 
expressing Xist transgenes from the Rosa26 locus was performed as described in Chapter 2.4.12. 
Mouse gene annotations (Release M1 NCBIM37) were downloaded from GENCODE (3) and 
separate annotation files were made with all annotated genes and all annotated exons. SNP-
overlapping reads were filtered for those which overlapped SNPs in genes using the intersect tool 
from BEDtools (94). These reads were then divided into reads overlapping exonic and intronic 
SNPs, again using the intersect tool. Reads were then assigned to specific genes, upper-quartile 
normalized, and plotted as described in Chapter 2.4.12. 
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3.4.2 Quantifying spliced and unspliced transcripts 
RNA sequencing from pSM33 cells inducibly expressing Xist from the endogenous locus 
was performed as described in Chapter 2.4.12. Sequencing reads were aligned to mm10 genomic 
sequence using Star (version 2.6.0a; (80)) with default parameters. All mm10 genome 
annotations were obtained from the UCSC genome browser (81). Only reads that had a mapping 
quality greater than or equal to 30 were used. Spliced and unspliced transcripts were quantified 
as described in Chapter 4.3.2 of (95). Briefly, reads were assigned to features twice using 
FeatureCounts (84). The first time, unspliced isoforms were quantified by assigning reads which 
fall entirely within intronic regions, and an expression value for unspliced expression was 
calculated by assuming the reads-per-base-pair (RPBP) across the unspliced transcript is 
uniform. The second time, spliced isoforms were quantified by passing an annotation file with 
unspliced and canonical spliced (if one exists) annotations for each gene to FeatureCounts and 
running with the ‘-O’ flag, which allows for each read to be assigned to more than one matched 
exon. Since each read assigned to the spliced isoform has some probability of actually deriving 
from the unspliced isoform, the unspliced RPBP calculated previously was subtracted from the 
spliced RPBP (calculated by dividing the FeatureCounts value by the length of the transcript). 
Values were then converted back to raw reads per region by multiplying RPBP by the length of 
the spliced transcript, and the datasets were normalized across all transcripts by calculating 
RPKM. 
Unspliced and spliced RPKM values for the genes which were significantly silenced by 
induction of Xist expression at 24h were set relative to 0h values and plotted as described in 
Chapter 2.4.12. 
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3.4.3 Extracting low-complexity domain amino acid sequences 
To extract amino acid sequences of low-complexity domains, sequence data were 
downloaded from Pfam (93). Specifically, the files ‘pfamseq.txt’ (which contains all protein 
amino acid sequences in the Pfam database) and ‘other_reg.txt’ (which contains the location of 
disordered domains predicted by the IUPred algorithm (96)) were downloaded from 
‘ftp://ftp.ebi.ac.uk/pub/databases/Pfam/current_release/database_files/’. Uniprot accession 
numbers for mouse and human proteins in the Pfam database were mapped to their gene names 
using an online tool (‘https://www.uniprot.org/uploadlists/’). Mouse and human protein 
sequences were pulled from ‘pfamseq.txt’ and printed as fasta files (‘mouse_proteins.fa’ and 
‘human_proteins.fa’) with headers formatted as ‘>uniprotaccession genename|species_info’. 
Where gene name was not available, gene description (from Pfam database) was used. Amino 
acid sequences of domains annotated as disordered in mouse and human proteins were pulled out 
of ‘pfamseq.txt’ and printed as fasta files (‘disoder.fa’) with headers formatted as 
‘>uniprotaccession.x genename|species_info’. The ‘x’ in the header represents the number of that 
disorder domain for that protein. Separate fasta files were also printed for all human disordered 
domains (‘human_disorder.fa’), all mouse disordered domains (‘mouse_disorder.fa’), all human 
disordered domains of at least 15 amino acids (‘human_15_disorder.fa’), and all mouse 
disordered domains of at least 15 amino acids (‘mouse_15_disorder.fa’). As of April 30, 2019, 
files were located in ‘/proj/calabrlb/users/david/forMauro/’ on the longleaf computing cluster. 
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Figure 3.1. Cellular localization is similar in reads overlapping exonic and intronic SNPs 
following expression of Xist transgenes from Rosa26. (A) Average allele-specific (B6) 
normalized cytosolic counts following expression of each Xist transgene relative to empty-cargo 
ESCs for transcripts overlapping exonic SNPs in the 205 genes significantly repressed by full-
length Xist. (B) Average allele-specific (B6) normalized nuclear counts following expression of 
each Xist transgene relative to empty-cargo ESCs for transcripts overlapping exonic SNPs in the 
205 genes significantly repressed by full-length Xist. (C-D) Similar to (A) and (B) but for 
transcripts overlapping intronic SNPs.  
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Figure 3.2. Cellular localization is similar in spliced and unspliced transcripts following 
expression of Xist from its endogenous locus in pSM33 ESCs. (A) Average normalized counts 
for spliced transcripts in the cytosolic fraction following Xist induction set relative to cells 
without Xist induction (0h) for the 275 genes silenced by full-length Xist at 24h. (B) Average 
normalized counts for spliced transcripts in the nuclear fraction following Xist induction set 
relative to cells without Xist induction (0h) for the 275 genes silenced by full-length Xist at 24h. 
(C-D) Similar to (A) and (B) but for unspliced transcripts.
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CHAPTER 4: DISCUSSION
We have described a novel and potentially very important aspect of Xist biology. In 
multiple genomic contexts, a portion of the Xist transcript is able to repress gene expression by 
sequestering target RNAs on chromatin, preventing their translation. To our knowledge, this is 
the first observed instance of lncRNAs influencing gene expression in this way. Though we have 
not yet observed sequestration in the context of full-length Xist expression, the role it plays in 
Xist activity overall remains an important question. At the simplest level, the ability of Xist-2kb 
to sequester transcripts suggests something interesting about how Xist and Repeat-A interact with 
target transcripts. Xist-2kb and other Xist hypomorphs, presumably through currently unknown 
protein cofactors, are able to interact with newly transcribed RNAs and prevent their export from 
the nucleus. In the context of full-length Xist, this interaction may not lead to sequestration, but it 
may still be important for proper Xist localization, stability, or further recruitment of additional 
protein cofactors which synergize to achieve transcriptional silencing. 
We sought to characterize Xist-mediated sequestration in multiple contexts, including 
expression of Xist-2kb from multiple genomic loci in polyclonal populations (TETRIS ESCs) 
and expression of single-copy Xist transgenes from the Rosa26 locus. We observed consistent 
sequestration of nearby transcripts by multiple hypomorphic versions of Xist (Figure 2.1, Figure 
2.2, and Figure 2.4). Sequestration depends on specific sequence elements within Xist, which 
also means that RNAs with similar sequences can display similar sequestration phenotypes 
(Figure 2.3). Knockdown of our top candidate proteins, SPEN and RBM15, had no effect on 
sequestration (Figure 2.5). We also showed that Xist-2kb-mediated recruitment of SPEN to 
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chromatin is insufficient to induce transcriptional silencing (Figure 2.5), suggesting that Xist-
induced silencing requires synergy between Repeat-A and other functional modules. 
Future work will focus on clarifying the mechanism of Xist-induced sequestration. We 
hypothesize that sequestration involves interactions with the transcription and splicing 
machinery, many protein components of which are already known to interact with Xist. One 
possibility is that Xist is interfering with RNA splicing, either by blocking access of splicing 
components or by sequestering them away from nascent transcripts by binding to Repeat-A. This 
block in splicing may itself result in reduced export. Initial analysis of the data herein did not 
show a clear increase in sequestration of unspliced transcripts (Figure 3.1 and Figure 3.2), but 
further experiments are ongoing to address these predictions. For example, efforts are underway 
to insert an intron in luciferase in the TETRIS construct to see if splicing of luciferase mRNA 
has any impact on sequestration. We predict that splicing will reduce sequestration, as splicing is 
known to promote more efficient nuclear export (92). 
Another major question going forward is whether we can identify protein cofactors 
required for Xist-induced sequestration. We are continuing targeted depletions of potential 
cofactors, working through a list of splicing- and export-related candidates. In parallel, we are 
preparing to perform a genome-wide knockdown screen using CRISPR/Cas9 (97). Because 
expression of Xist-2kb from the Rosa26 locus in our RMCE cells leads to sequestration of 
HygroR mRNA (Figure 2.4), the cells become sensitive to hygromycin treatment. By knocking 
down proteins genome-wide and treating with hygromycin, we can enrich for cells with reduced 
sequestration resulting from knockdown of a particular protein. 
Xist is a fascinating example of lncRNA function. Its ability to silence an entire 
chromosome is unmatched, and the stability of the silencing is such that the Xi remains silenced 
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through all subsequent cell divisions throughout life. Study of Xist provides an important 
opportunity to understand how lncRNAs can contribute to gene expression regulation. The 
specific set of proteins recruited by Xist may be quite similar to those recruited by other RNAs 
which regulate transcription. Additionally, differences in the specific proteins recruited may shed 
light on how Xist is able to operate with such potency on such a large scale. More broadly, we 
have seen that Xist displays programmed modularity in the way it recruits proteins, and that the 
synergy between these modules and their respective proteins is important for the overall function 
of Xist. This synergy between modules is likely to be an important aspect of functional RNAs 
and RNA-binding proteins, so dissecting Xist and its mechanism is an important contribution to 
understanding RNA biology in general. 
More broadly, the more we understand about how Xist operates, the more we learn about 
genome regulation in general. As discussed in Chapter 1, genome regulation is central to 
biology. New insights into how Xist functions to modulate gene expression are important in their 
own right, as Xist and XCI are important aspects of normal human development, but they will 
also shed light on other mechanisms of genome regulation. As we seek to harness the power of 
genomics to combat clinical issues like cancer, increasing our understanding of proper genome 
regulation and how it becomes disordered is crucial. We are eager to see how our contributions 
to unraveling the ways in which Xist operates are applied to other areas in epigenetics and gene 
expression regulation. Further, we are confident that the research we and others are doing to 
understand this remarkable molecule will continue to have implications in understanding how 
genome regulation is perturbed in cancer and other disorders, now and in the future. In this way, 
Xist research is an exciting example of the power of basic science research on fundamental 
mechanisms and how it can have far-reaching implications.
77 
REFERENCES 
1. Fang, S., Zhang, L., Guo, J., Niu, Y., Wu, Y., Li, H., Zhao, L., Li, X., Teng, X., Sun, X. 
et al. (2018) NONCODEV5: a comprehensive annotation database for long non-coding 
RNAs. Nucleic Acids Res, 46, D308-D314. 
2. Kopp, F. and Mendell, J.T. (2018) Functional Classification and Experimental Dissection 
of Long Noncoding RNAs. Cell, 172, 393-407. 
3. Frankish, A., Diekhans, M., Ferreira, A.M., Johnson, R., Jungreis, I., Loveland, J., 
Mudge, J.M., Sisu, C., Wright, J., Armstrong, J. et al. (2019) GENCODE reference 
annotation for the human and mouse genomes. Nucleic Acids Res, 47, D766-D773. 
4. Engreitz, J.M., Ollikainen, N. and Guttman, M. (2016) Long non-coding RNAs: spatial 
amplifiers that control nuclear structure and gene expression. Nat Rev Mol Cell Biol, 17, 
756-770. 
5. Fatica, A. and Bozzoni, I. (2014) Long non-coding RNAs: new players in cell 
differentiation and development. Nat Rev Genet, 15, 7-21. 
6. Kanduri, C. (2016) Long noncoding RNAs: Lessons from genomic imprinting. Biochim 
Biophys Acta, 1859, 102-111. 
7. Fortes, P. and Morris, K.V. (2016) Long noncoding RNAs in viral infections. Virus Res, 
212, 1-11. 
8. Marchese, F.P. and Huarte, M. (2014) Long non-coding RNAs and chromatin modifiers: 
their place in the epigenetic code. Epigenetics, 9, 21-26. 
9. Yoon, J.H., Abdelmohsen, K. and Gorospe, M. (2013) Posttranscriptional gene regulation 
by long noncoding RNA. J Mol Biol, 425, 3723-3730. 
10. Huarte, M. (2015) The emerging role of lncRNAs in cancer. Nat Med, 21, 1253-1261. 
11. Wapinski, O. and Chang, H.Y. (2011) Long noncoding RNAs and human disease. Trends 
Cell Biol, 21, 354-361. 
12. Lee, J.T. and Bartolomei, M.S. (2013) X-inactivation, imprinting, and long noncoding 
RNAs in health and disease. Cell, 152, 1308-1323. 
13. Chu, C., Zhang, Q.C., da Rocha, S.T., Flynn, R.A., Bharadwaj, M., Calabrese, J.M., 
Magnuson, T., Heard, E. and Chang, H.Y. (2015) Systematic discovery of Xist RNA 
binding proteins. Cell, 161, 404-416. 
14. Pintacuda, G., Wei, G., Roustan, C., Kirmizitas, B.A., Solcan, N., Cerase, A., Castello, 
A., Mohammed, S., Moindrot, B., Nesterova, T.B. et al. (2017) hnRNPK Recruits 
PCGF3/5-PRC1 to the Xist RNA B-Repeat to Establish Polycomb-Mediated 
Chromosomal Silencing. Mol Cell, 68, 955-969 e910. 
78 
15. Ridings-Figueroa, R., Stewart, E.R., Nesterova, T.B., Coker, H., Pintacuda, G., Godwin, 
J., Wilson, R., Haslam, A., Lilley, F., Ruigrok, R. et al. (2017) The nuclear matrix protein 
CIZ1 facilitates localization of Xist RNA to the inactive X-chromosome territory. Genes 
Dev, 31, 876-888. 
16. Sunwoo, H., Colognori, D., Froberg, J.E., Jeon, Y. and Lee, J.T. (2017) Repeat E anchors 
Xist RNA to the inactive X chromosomal compartment through CDKN1A-interacting 
protein (CIZ1). Proc Natl Acad Sci U S A, 114, 10654-10659. 
17. Lu, Z., Carter, A.C. and Chang, H.Y. (2017) Mechanistic insights in X-chromosome 
inactivation. Philos Trans R Soc Lond B Biol Sci, 372. 
18. Brockdorff, N., Ashworth, A., Kay, G.F., McCabe, V.M., Norris, D.P., Cooper, P.J., 
Swift, S. and Rastan, S. (1992) The product of the mouse Xist gene is a 15 kb inactive X-
specific transcript containing no conserved ORF and located in the nucleus. Cell, 71, 515-
526. 
19. Brown, C.J., Hendrich, B.D., Rupert, J.L., Lafreniere, R.G., Xing, Y., Lawrence, J. and 
Willard, H.F. (1992) The human XIST gene: analysis of a 17 kb inactive X-specific RNA 
that contains conserved repeats and is highly localized within the nucleus. Cell, 71, 527-
542. 
20. Yen, Z.C., Meyer, I.M., Karalic, S. and Brown, C.J. (2007) A cross-species comparison 
of X-chromosome inactivation in Eutheria. Genomics, 90, 453-463. 
21. Nesterova, T.B., Slobodyanyuk, S.Y., Elisaphenko, E.A., Shevchenko, A.I., Johnston, C., 
Pavlova, M.E., Rogozin, I.B., Kolesnikov, N.N., Brockdorff, N. and Zakian, S.M. (2001) 
Characterization of the genomic Xist locus in rodents reveals conservation of overall 
gene structure and tandem repeats but rapid evolution of unique sequence. Genome Res, 
11, 833-849. 
22. McHugh, C.A., Chen, C.K., Chow, A., Surka, C.F., Tran, C., McDonel, P., Pandya-Jones, 
A., Blanco, M., Burghard, C., Moradian, A. et al. (2015) The Xist lncRNA interacts 
directly with SHARP to silence transcription through HDAC3. Nature, 521, 232-236. 
23. Minajigi, A., Froberg, J.E., Wei, C., Sunwoo, H., Kesner, B., Colognori, D., Lessing, D., 
Payer, B., Boukhali, M., Haas, W. et al. (2015) A comprehensive Xist interactome 
reveals cohesin repulsion and an RNA-directed chromosome conformation. Science. 
24. Moindrot, B., Cerase, A., Coker, H., Masui, O., Grijzenhout, A., Pintacuda, G., 
Schermelleh, L., Nesterova, T.B. and Brockdorff, N. (2015) A Pooled shRNA Screen 
Identifies Rbm15, Spen, and Wtap as Factors Required for Xist RNA-Mediated 
Silencing. Cell Rep, 12, 562-572. 
25. Monfort, A., Di Minin, G., Postlmayr, A., Freimann, R., Arieti, F., Thore, S. and Wutz, 
A. (2015) Identification of Spen as a Crucial Factor for Xist Function through Forward 
Genetic Screening in Haploid Embryonic Stem Cells. Cell Rep, 12, 554-561. 
79 
26. Ariyoshi, M. and Schwabe, J.W. (2003) A conserved structural motif reveals the essential 
transcriptional repression function of Spen proteins and their role in developmental 
signaling. Genes Dev, 17, 1909-1920. 
27. Oswald, F., Kostezka, U., Astrahantseff, K., Bourteele, S., Dillinger, K., Zechner, U., 
Ludwig, L., Wilda, M., Hameister, H., Knochel, W. et al. (2002) SHARP is a novel 
component of the Notch/RBP-Jkappa signalling pathway. EMBO J, 21, 5417-5426. 
28. Shi, Y., Downes, M., Xie, W., Kao, H.Y., Ordentlich, P., Tsai, C.C., Hon, M. and Evans, 
R.M. (2001) Sharp, an inducible cofactor that integrates nuclear receptor repression and 
activation. Genes Dev, 15, 1140-1151. 
29. Schoeftner, S., Sengupta, A.K., Kubicek, S., Mechtler, K., Spahn, L., Koseki, H., 
Jenuwein, T. and Wutz, A. (2006) Recruitment of PRC1 function at the initiation of X 
inactivation independent of PRC2 and silencing. EMBO J, 25, 3110-3122. 
30. Silva, J., Mak, W., Zvetkova, I., Appanah, R., Nesterova, T.B., Webster, Z., Peters, A.H., 
Jenuwein, T., Otte, A.P. and Brockdorff, N. (2003) Establishment of histone h3 
methylation on the inactive X chromosome requires transient recruitment of Eed-Enx1 
polycomb group complexes. Dev Cell, 4, 481-495. 
31. de Napoles, M., Mermoud, J.E., Wakao, R., Tang, Y.A., Endoh, M., Appanah, R., 
Nesterova, T.B., Silva, J., Otte, A.P., Vidal, M. et al. (2004) Polycomb group proteins 
Ring1A/B link ubiquitylation of histone H2A to heritable gene silencing and X 
inactivation. Dev Cell, 7, 663-676. 
32. Hasegawa, Y., Brockdorff, N., Kawano, S., Tsutui, K., Tsutui, K. and Nakagawa, S. 
(2010) The matrix protein hnRNP U is required for chromosomal localization of Xist 
RNA. Dev Cell, 19, 469-476. 
33. Patil, D.P., Chen, C.K., Pickering, B.F., Chow, A., Jackson, C., Guttman, M. and Jaffrey, 
S.R. (2016) m(6)A RNA methylation promotes XIST-mediated transcriptional 
repression. Nature, 537, 369-+. 
34. Tsai, M.C., Manor, O., Wan, Y., Mosammaparast, N., Wang, J.K., Lan, F., Shi, Y., Segal, 
E. and Chang, H.Y. (2010) Long noncoding RNA as modular scaffold of histone 
modification complexes. Science, 329, 689-693. 
35. Lu, Z.P., Zhang, Q.C., Lee, B., Flynn, R.A., Smith, M.A., Robinson, J.T., Davidovich, 
C., Gooding, A.R., Goodrich, K.J., Mattick, J.S. et al. (2016) RNA Duplex Map in Living 
Cells Reveals Higher-Order Transcriptome Structure. Cell, 165, 1267-1279. 
36. Liu, F., Somarowthu, S. and Pyle, A.M. (2017) Visualizing the secondary and tertiary 
architectural domains of lncRNA RepA. Nat Chem Biol, 13, 282-289. 
37. Somarowthu, S., Legiewicz, M., Chillon, I., Marcia, M., Liu, F. and Pyle, A.M. (2015) 
HOTAIR forms an intricate and modular secondary structure. Mol Cell, 58, 353-361. 
80 
38. Smola, M.J., Christy, T.W., Inoue, K., Nicholson, C.O., Friedersdorf, M., Keene, J.D., 
Lee, D.M., Calabrese, J.M. and Weeks, K.M. (2016) SHAPE reveals transcript-wide 
interactions, complex structural domains, and protein interactions across the Xist lncRNA 
in living cells. Proc Natl Acad Sci U S A, 113, 10322-10327. 
39. Sunwoo, H., Wu, J.Y. and Lee, J.T. (2015) The Xist RNA-PRC2 complex at 20-nm 
resolution reveals a low Xist stoichiometry and suggests a hit-and-run mechanism in 
mouse cells. Proc Natl Acad Sci U S A, 112, E4216-4225. 
40. Wutz, A., Rasmussen, T.P. and Jaenisch, R. (2002) Chromosomal silencing and 
localization are mediated by different domains of Xist RNA. Nat Genet, 30, 167-174. 
41. Kohlmaier, A., Savarese, F., Lachner, M., Martens, J., Jenuwein, T. and Wutz, A. (2004) 
A chromosomal memory triggered by Xist regulates histone methylation in X 
inactivation. PLoS Biol, 2, E171. 
42. Chaumeil, J., Le Baccon, P., Wutz, A. and Heard, E. (2006) A novel role for Xist RNA in 
the formation of a repressive nuclear compartment into which genes are recruited when 
silenced. Genes Dev, 20, 2223-2237. 
43. Cirillo, D., Blanco, M., Armaos, A., Buness, A., Avner, P., Guttman, M., Cerase, A. and 
Tartaglia, G.G. (2016) Quantitative predictions of protein interactions with long 
noncoding RNAs. Nat Methods, 14, 5-6. 
44. Hoki, Y., Kimura, N., Kanbayashi, M., Amakawa, Y., Ohhata, T., Sasaki, H. and Sado, 
T. (2009) A proximal conserved repeat in the Xist gene is essential as a genomic element 
for X-inactivation in mouse. Development, 136, 139-146. 
45. Royce-Tolland, M.E., Andersen, A.A., Koyfman, H.R., Talbot, D.J., Wutz, A., Tonks, 
I.D., Kay, G.F. and Panning, B. (2010) The A-repeat links ASF/SF2-dependent Xist RNA 
processing with random choice during X inactivation. Nat Struct Mol Biol, 17, 948-954. 
46. Engreitz, J.M., Pandya-Jones, A., McDonel, P., Shishkin, A., Sirokman, K., Surka, C., 
Kadri, S., Xing, J., Goren, A., Lander, E.S. et al. (2013) The Xist lncRNA exploits three-
dimensional genome architecture to spread across the X chromosome. Science, 341, 
1237973. 
47. Chigi, Y., Sasaki, H. and Sado, T. (2017) The 5' region of Xist RNA has the potential to 
associate with chromatin through the A-repeat. RNA, 23, 1894-1901. 
48. Ha, N., Lai, L.T., Chelliah, R., Zhen, Y., Yi Vanessa, S.P., Lai, S.K., Li, H.Y., Ludwig, 
A., Sandin, S., Chen, L. et al. (2018) Live-Cell Imaging and Functional Dissection of 
Xist RNA Reveal Mechanisms of X Chromosome Inactivation and Reactivation. 
iScience, 8, 1-14. 
49. Kirk, J.M., Kim, S.O., Inoue, K., Smola, M.J., Lee, D.M., Schertzer, M.D., Wooten, J.S., 
Baker, A.R., Sprague, D., Collins, D.W. et al. (2018) Functional classification of long 
non-coding RNAs by k-mer content. Nat Genet, 50, 1474-1482. 
81 
50. Hoki, Y., Ikeda, R., Mise, N., Sakata, Y., Ohhata, T., Sasaki, H., Abe, K. and Sado, T. 
(2011) Incomplete X-inactivation initiated by a hypomorphic Xist allele in the mouse. 
Development, 138, 2649-2659. 
51. Bhatt, D.M., Pandya-Jones, A., Tong, A.J., Barozzi, I., Lissner, M.M., Natoli, G., Black, 
D.L. and Smale, S.T. (2012) Transcript dynamics of proinflammatory genes revealed by 
sequence analysis of subcellular RNA fractions. Cell, 150, 279-290. 
52. Wysocka, J., Reilly, P.T. and Herr, W. (2001) Loss of HCF-1-chromatin association 
precedes temperature-induced growth arrest of tsBN67 cells. Mol Cell Biol, 21, 3820-
3829. 
53. Presnyak, V., Alhusaini, N., Chen, Y.H., Martin, S., Morris, N., Kline, N., Olson, S., 
Weinberg, D., Baker, K.E., Graveley, B.R. et al. (2015) Codon optimality is a major 
determinant of mRNA stability. Cell, 160, 1111-1124. 
54. Adelman, K. and Lis, J.T. (2012) Promoter-proximal pausing of RNA polymerase II: 
emerging roles in metazoans. Nat Rev Genet, 13, 720-731. 
55. Dunagin, M., Cabili, M.N., Rinn, J. and Raj, A. (2015) Visualization of lncRNA by 
single-molecule fluorescence in situ hybridization. Methods Mol Biol, 1262, 3-19. 
56. Chen, S.X., Osipovich, A.B., Ustione, A., Potter, L.A., Hipkens, S., Gangula, R., Yuan, 
W.P., Piston, D.W. and Magnuson, M.A. (2011) Quantification of factors influencing 
fluorescent protein expression using RMCE to generate an allelic series in the ROSA26 
locus in mice. Dis Model Mech, 4, 537-547. 
57. Yamada, N., Hasegawa, Y., Yue, M., Hamada, T., Nakagawa, S. and Ogawa, Y. (2015) 
Xist Exon 7 Contributes to the Stable Localization of Xist RNA on the Inactive X-
Chromosome. PLoS Genet, 11, e1005430. 
58. Gossen, M., Freundlieb, S., Bender, G., Muller, G., Hillen, W. and Bujard, H. (1995) 
Transcriptional activation by tetracyclines in mammalian cells. Science, 268, 1766-1769. 
59. Raab, J.R., Smith, K.N., Spear, C.C., Manner, C.J., Calabrese, J.M. and Magnuson, T. 
(2019) SWI/SNF remains localized to chromatin in the presence of SCHLAP1. Nat 
Genet, 51, 26-29. 
60. Chen, L.L. and Carmichael, G.G. (2009) Altered nuclear retention of mRNAs containing 
inverted repeats in human embryonic stem cells: functional role of a nuclear noncoding 
RNA. Mol Cell, 35, 467-478. 
61. Prasanth, K.V., Prasanth, S.G., Xuan, Z., Hearn, S., Freier, S.M., Bennett, C.F., Zhang, 
M.Q. and Spector, D.L. (2005) Regulating gene expression through RNA nuclear 
retention. Cell, 123, 249-263. 
62. Tripathi, V., Ellis, J.D., Shen, Z., Song, D.Y., Pan, Q., Watt, A.T., Freier, S.M., Bennett, 
C.F., Sharma, A., Bubulya, P.A. et al. (2010) The nuclear-retained noncoding RNA 
82 
MALAT1 regulates alternative splicing by modulating SR splicing factor 
phosphorylation. Mol Cell, 39, 925-938. 
63. Ntini, E., Louloupi, A., Liz, J., Muino, J.M., Marsico, A. and Orom, U.A.V. (2018) Long 
ncRNA A-ROD activates its target gene DKK1 at its release from chromatin. Nat 
Commun, 9, 1636. 
64. Reyes-Turcu, F.E. and Grewal, S.I. (2012) Different means, same end-heterochromatin 
formation by RNAi and RNAi-independent RNA processing factors in fission yeast. Curr 
Opin Genet Dev, 22, 156-163. 
65. Minks, J., Baldry, S.E., Yang, C., Cotton, A.M. and Brown, C.J. (2013) XIST-induced 
silencing of flanking genes is achieved by additive action of repeat a monomers in human 
somatic cells. Epigenetics Chromatin, 6, 23. 
66. Huelga, S.C., Vu, A.Q., Arnold, J.D., Liang, T.Y., Liu, P.P., Yan, B.Y., Donohue, J.P., 
Shiue, L., Hoon, S., Brenner, S. et al. (2012) Integrative genome-wide analysis reveals 
cooperative regulation of alternative splicing by hnRNP proteins. Cell Rep, 1, 167-178. 
67. Van Nostrand, E.L., Pratt, G.A., Shishkin, A.A., Gelboin-Burkhart, C., Fang, M.Y., 
Sundararaman, B., Blue, S.M., Nguyen, T.B., Surka, C., Elkins, K. et al. (2016) Robust 
transcriptome-wide discovery of RNA-binding protein binding sites with enhanced CLIP 
(eCLIP). Nat Methods, 13, 508-514. 
68. Hornyik, C., Terzi, L.C. and Simpson, G.G. (2010) The spen family protein FPA controls 
alternative cleavage and polyadenylation of RNA. Dev Cell, 18, 203-213. 
69. Lindtner, S., Zolotukhin, A.S., Uranishi, H., Bear, J., Kulkarni, V., Smulevitch, S., 
Samiotaki, M., Panayotou, G., Felber, B.K. and Pavlakis, G.N. (2006) RNA-binding 
motif protein 15 binds to the RNA transport element RTE and provides a direct link to 
the NXF1 export pathway. J Biol Chem, 281, 36915-36928. 
70. Majerciak, V., Uranishi, H., Kruhlak, M., Pilkington, G.R., Massimelli, M.J., Bear, J., 
Pavlakis, G.N., Felber, B.K. and Zheng, Z.M. (2011) Kaposi's sarcoma-associated 
herpesvirus ORF57 interacts with cellular RNA export cofactors RBM15 and OTT3 to 
promote expression of viral ORF59. J Virol, 85, 1528-1540. 
71. Uranishi, H., Zolotukhin, A.S., Lindtner, S., Warming, S., Zhang, G.M., Bear, J., 
Copeland, N.G., Jenkins, N.A., Pavlakis, G.N. and Felber, B.K. (2009) The RNA-binding 
motif protein 15B (RBM15B/OTT3) acts as cofactor of the nuclear export receptor 
NXF1. J Biol Chem, 284, 26106-26116. 
72. Chen, C.K., Blanco, M., Jackson, C., Aznauryan, E., Ollikainen, N., Surka, C., Chow, A., 
Cerase, A., McDonel, P. and Guttman, M. (2016) Xist recruits the X chromosome to the 
nuclear lamina to enable chromosome-wide silencing. Science, 354, 468-472. 
83 
73. Beermann, F., Hummler, E., Schmid, E. and Schutz, G. (1993) Perinatal activation of a 
tyrosine aminotransferase fusion gene does not occur in albino lethal mice. Mech Dev, 
42, 59-65. 
74. Southern, E. (2006) Southern blotting. Nat Protoc, 1, 518-525. 
75. Gibson, D.G. (2011) Enzymatic assembly of overlapping DNA fragments. Methods 
Enzymol, 498, 349-361. 
76. Sayers, J.R., Evans, D. and Thomson, J.B. (1996) Identification and eradication of a 
denatured DNA isolated during alkaline lysis-based plasmid purification procedures. 
Anal Biochem, 241, 186-189. 
77. Chan, W., Costantino, N., Li, R., Lee, S.C., Su, Q., Melvin, D., Court, D.L. and Liu, P. 
(2007) A recombineering based approach for high-throughput conditional knockout 
targeting vector construction. Nucleic Acids Res, 35, e64. 
78. Sharan, S.K., Thomason, L.C., Kuznetsov, S.G. and Court, D.L. (2009) Recombineering: 
a homologous recombination-based method of genetic engineering. Nat Protoc, 4, 206-
223. 
79. Kirk, J.M., Kim, S.O., Inoue, K., M.J., S., Lee, D.M., Schertzer, M.D., Wooten, J.S., 
Baker, A.R., Sprague, D., Collins, D.W. et al. (2018) Functional classification of long 
non-coding RNAs by kmer content. Nature Genetics, In press. 
80. Dobin, A., Davis, C.A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., 
Chaisson, M. and Gingeras, T.R. (2013) STAR: ultrafast universal RNA-seq aligner. 
Bioinformatics, 29, 15-21. 
81. Casper, J., Zweig, A.S., Villarreal, C., Tyner, C., Speir, M.L., Rosenbloom, K.R., Raney, 
B.J., Lee, C.M., Lee, B.T., Karolchik, D. et al. (2018) The UCSC Genome Browser 
database: 2018 update. Nucleic Acids Res, 46, D762-D769. 
82. Calabrese, J.M., Starmer, J., Schertzer, M.D., Yee, D. and Magnuson, T. (2015) A survey 
of imprinted gene expression in mouse trophoblast stem cells. G3 (Bethesda), 5, 751-759. 
83. Calabrese, J.M., Sun, W., Song, L., Mugford, J.W., Williams, L., Yee, D., Starmer, J., 
Mieczkowski, P., Crawford, G.E. and Magnuson, T. (2012) Site-specific silencing of 
regulatory elements as a mechanism of X inactivation. Cell, 151, 951-963. 
84. Liao, Y., Smyth, G.K. and Shi, W. (2014) featureCounts: an efficient general purpose 
program for assigning sequence reads to genomic features. Bioinformatics, 30, 923-930. 
85. Love, M.I., Huber, W. and Anders, S. (2014) Moderated estimation of fold change and 
dispersion for RNA-seq data with DESeq2. Genome Biol, 15, 550. 
86. Team, R.C. (2018) R: A language and environment for statistical computing. R 
Foundation for Statistical Computing, Vienna, Austria. 
84 
87. Hendrickson, D.G., Kelley, D.R., Tenen, D., Bernstein, B. and Rinn, J.L. (2016) 
Widespread RNA binding by chromatin-associated proteins. Genome Biology, 17. 
88. Cong, L., Ran, F.A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P.D., Wu, X., Jiang, 
W., Marraffini, L.A. et al. (2013) Multiplex genome engineering using CRISPR/Cas 
systems. Science, 339, 819-823. 
89. Pulido-Quetglas, C., Aparicio-Prat, E., Arnan, C., Polidori, T., Hermoso, T., Palumbo, E., 
Ponomarenko, J., Guigo, R. and Johnson, R. (2017) Scalable Design of Paired CRISPR 
Guide RNAs for Genomic Deletion. PLoS Comput Biol, 13, e1005341. 
90. Stork, C., Li, Z., Lin, L. and Zheng, S. (2018) Developmental Xist induction is mediated 
by enhanced splicing. Nucleic Acids Res. 
91. Gil, N. and Ulitsky, I. (2018) Production of Spliced Long Noncoding RNAs Specifies 
Regions with Increased Enhancer Activity. Cell Syst, 7, 537-547 e533. 
92. Valencia, P., Dias, A.P. and Reed, R. (2008) Splicing promotes rapid and efficient 
mRNA export in mammalian cells. Proc Natl Acad Sci U S A, 105, 3386-3391. 
93. El-Gebali, S., Mistry, J., Bateman, A., Eddy, S.R., Luciani, A., Potter, S.C., Qureshi, M., 
Richardson, L.J., Salazar, G.A., Smart, A. et al. (2019) The Pfam protein families 
database in 2019. Nucleic Acids Res, 47, D427-D432. 
94. Quinlan, A.R. and Hall, I.M. (2010) BEDTools: a flexible suite of utilities for comparing 
genomic features. Bioinformatics, 26, 841-842. 
95. Kirk, J.M. (2019) PhD dissertation, University of North Carolina at Chapel Hill. 
96. Dosztanyi, Z., Csizmok, V., Tompa, P. and Simon, I. (2005) IUPred: web server for the 
prediction of intrinsically unstructured regions of proteins based on estimated energy 
content. Bioinformatics, 21, 3433-3434. 
97. Sanson, K.R., Hanna, R.E., Hegde, M., Donovan, K.F., Strand, C., Sullender, M.E., 
Vaimberg, E.W., Goodale, A., Root, D.E., Piccioni, F. et al. (2018) Optimized libraries 
for CRISPR-Cas9 genetic screens with multiple modalities. Nat Commun, 9, 5416. 
  
